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It is broadly acknowledged that among the lesions that may be induced in the 
DNA, the most critical biological effects are generated by those affecting both 
strands of the deoxyribonucleic acid (DNA). Such lesions risk the genome, 
whose maintenance of utmost importance for every organism is. Damage in the 
genome of eukaryotic cells can be generated by ionizing radiation (IR) (Ward, 
1988) or could emerge as consequence of exposure of cells to a variety of 
exogenous DNA damaging agents like cosmic and terrestrial radiation, chemical 
compounds (Sato et al., 1983) and radiomimetic drugs (Ackland et al., 1988; 
Elmroth et al., 2003). Lesions in the DNA can also appear as a result of 
endogenous cellular processes such as spontaneous chemical alterations in 
biological molecules, reactive oxygen species (ROS), by-products of 
intracellular metabolism (Helleday et al., 2007) and faults of biochemical 
processes related to DNA metabolism, such as DNA replication (Arnaudeau et 
al., 2001). The final event in all of the above situations can be the generation of 
DNA double strand breaks (DSBs). In contrast to the randomly induced DSB 
induced by the above mentioned processes, DSBs can also be generated by 
programmed events in essential cellular processes such as meiosis 
(Richardson et al., 2004), or V(D)J- and class switch (CS) recombination during 
the maturation of lymphoid cells (Bassing et al., 2002; Petersen et al., 2001). 
As a result of ionizing radiation exposure to a dose of 1 Gy of X-rays, over 1000 
single strand breaks (SSBs), an equal number of base damages, but only 20-40 
DSBs are generated (Ward, 1990). DSBs are one of the most severe DNA 
lesions and, if left unrepaired, can lead to permanent cell cycle arrest, induction 
of apoptosis, or cell killing (Olive, 1998). If these lesions are misrepaired, they 
can result in mutations, chromosome rearrangements and carcinogenesis 
(Jackson, 2002) through translocations, inversions, or deletions (van Gent et al., 
2001). Over the evolution, cells have developed sophisticated and efficient 




response (DDR) mechanisms. DDR includes a repair network efficient enough 
to deal with the abundance of DNA lesions generated by ionizing irradiation and 
helps thus to maintain genomic integrity. 
Eukaryotic cells utilize at least two major repair pathways to restore the duplex 
structure of their genome: homologous recombination repair (HRR) and 
non-homologous end-joining (NHEJ). These mechanistically distinct pathways 
are not biochemically equivalent, have different substrate requirements, operate 
with different kinetics and fidelity, and are utilized differently throughout the cell 
cycle (Tamulevicius et al., 2007). Such repair activities are supported by an 
extensive network of signaling proteins, which registers DSBs and coordinates 
repair with the activation of checkpoints that arrest the normal progression 
through the cell cycle to provide time for repair (Elledge, 1996; Niida and 
Nakanishi, 2006). On which basis the cell decides to use HRR or NHEJ for the 
repair of a certain DSB is still an area of active investigation. Recent studies 
suggest that components of one repair pathways may regulate key events of 
the other pathway, thus shifting pathway use. Hence, the Ku70/80 complex 
together with the DNA Ligase IV complex are thought to be key suppressors of 
DNA end-resection, which is needed to initiate HRR (Zhang et al., 2007).  
In the following chapters, the basics of radiation physics are outlined together 
with a description of the basic properties and characteristics of the DSB repair 
pathways, with particular emphasis on the role of DNA ligases in the process. 
This generates the foundation and the theoretical background for the work 





1.2 Ionizing radiation and the induction of DNA 
damage 
1.2.1 Physics of ionizing radiation 
In this thesis X-rays were used to generate DNA damage and investigate 
cellular repair pathways engaged. To facilitate understanding of the 
mechanisms of DNA damage induction by X-rays, I present here a short 
introduction into the physics of ionizing radiation. In physics, ionizing radiation 
(IR) describes any process in which energy emitted by an object travels through 
a medium or space, and is finally absorbed by another object, thus resulting in 
excitation or ionization of its atoms. There are several forms of electromagnetic 
radiation that are classified by the frequency and energy of their wavelengths. A 
photon is the basic “unit” of all forms of electromagnetic radiation. The 
electromagnetic spectrum consists of radio waves, microwaves, infrared 
radiation, visible light, ultraviolet radiation (UV), X-rays and -rays; they all vary 
in their frequency and wavelength, and hence in the energy of constituting 
photons. In general, photons of high wavelength and low frequency have low 
energy contrary to those of low wavelength and high frequency, which have 
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ionizing. Directly ionizing radiation constitutes charged particles that have 
sufficient kinetic energy to disrupt atomic structure of the absorber, directly 
producing chemical and biological changes within the absorber. In contrast, 
electromagnetic radiation is considered indirectly ionizing, as it deposits the 
majority of its energy through the production of secondary electrons (see below) 
(Konkow, 2012). 
Radiation is measured in units of Gray (Gy) describing the amount of energy 
absorbed per unit mass of matter. The unit of 1 Gy corresponds to 1 J/kg (Hall 
and Giaccia, 2006). The absorbed energy, deposited by IR, is not distributed at 
random but tends to localize along the tracks of directly ionizing particles in a 
pattern that is determined by their type, energy and speed (Mothersill and 
Seymour, 2006). One can distinguish between densely and sparsely ionizing 
radiation depending on the ionization patterns it generates. This property is 
described by the parameter linear energy transfer (LET) that is defined as the 
energy that an ionizing particle deposits along the track (keV/µm) as it traverses 
matter. LET also reflects the pattern of ionizations a type of radiation generates. 
Sparsely ionizing radiation is of low LET, whereas densely ionizing radiation is 
of high LET (Konkow, 2012). 
It is important to note that the biological effects of a type of radiation depend 
strongly on its LET, and increases with increasing LET. X-rays and -rays are 
mostly low LET radiations, whereas charged particles are generally high LET 
radiations, e.g. α-irradiation is a high LET radiation with low penetration depth 
(Hall and Giaccia, 2006). For charged particles, the density of ionizations 
decreases as the particle energy increases (Konkow, 2012). Figure 2 presents 
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labile sites (Singh et al., 2009) together with many crosslinks between different 
chromatin associated proteins and the DNA (Konkow, 2012). 
Lesions in the DNA backbone include abasic sites, single strand (ss) and 
double strand (ds) DNA breaks. As mentioned above, each Gy of X-rays 
induces around 20-40 prompt DSBs, ~1000 single strand breaks (SSBs) and an 
equal number of base damages (Ward, 1990). SSBs have small biological 
consequences, since they can be repaired very fast by using the 
complementary strand as a DNA template. However, if SSBs occur opposite to 
each other, or are separated by up to ten base pairs (bp) on opposite sides of 
the DNA strand, a DSB is generated. If this lesion is left unrepaired or is 
misrepaired it could lead to genomic instability, cell death, carcinogenesis or 
mutations as well. In summary, DNA damage produced by direct or indirect 
radiation action leads to changes in the character and the properties of the 
molecule, and impairs thus its function as carrier of genetic information. As a 
result, cell death, mutation and/or transformation can ensue (Konkow, 2012). 
1.3 Non-Ionizing radiation 
Beyond the ability of photons to ionize atoms, within the electromagnetic 
spectrum photons with energies below 10 eV are considered as non-ionizing 
(Figure 1). This means that i.e. UV radiation with wavelengths longer than 124 
nanometers (nm) is non-ionizing radiation. Instead of “kicking-out” an electron 
and producing charged ions, this form of electromagnetic radiation has sufficient 
energy only for excitations, i.e. the movement of an electron to a higher energy 
state. 
The electromagnetic spectrum of UV lies between X-rays and visible light with 
wavelengths between 40 and 400 nm (30-3 eV). The UV spectrum is divided 
into Vacuum UV (40-190 nm), Far UV (190-220 nm), UVC (220-290 nm), UVB 
(290-320), and UVA (320-400 nm). However, the UV spectrum from 3 to 10 eV, 
although technically designated as non-ionizing, can produce photochemical 
reactions to many molecules and is doing far more damage than can be 




radicals, it is capable of non-thermal damage in biological systems that have 
some of the biological features of ionizing radiation. UVC also induces helix 
distorting DNA lesions like cyclobutane pyrimidine dimers (CPDs) and 
6-4 pyrimidine-pyrimidone photoproducts (6-4PPs) between adjacent pyrimidine 
residues. 
1.4 Eukaryotic DSB repair and its regulation 
After DNA damage induction cells start to eliminate the generated DSBs by the 
activation of their DNA repair machinery. Higher eukaryotic cells utilize two main 
repair pathways to remove DSBs from their genomes – NHEJ and HRR. The 
fundamental difference between these two repair pathways is that HRR requires 
a homologous template to restore accurately the DNA sequence around the 
break, whereas NHEJ simply rejoins the two ends of the DSB (Essers et al., 
2000). Consequently, HRR ensures correct repair of the DSB by using either an 
undamaged sister chromatid or a homologous chromosome as a repair 
template (Khanna and Jackson, 2001); on the other hand, NHEJ rejoins the two 
DNA ends without any requirement for homology (Karran, 2000), hence the 
term “non-homologous end-joining” (Weterings and Chen, 2008). Repair of 
DSBs by NHEJ is usually accompanied by limited or extensive additions or 
deletions of nucleotides at the junction, also in order to produce ligatable ends. 
The result is altered sequence of the repaired DNA molecule - due to the fact 
that NHEJ does not restore sequence information in the damaged DNA 
molecule, although it restores its molecular integrity (Iliakis et al., 2004; Lieber, 
2010). Thus, DSB repair by NHEJ is considered as error-prone. 
The relative contribution of the two repair pathways to the repair of DSBs is 
likely to be determined by the phase of the cell cycle and the presence of a 
homologous DNA template, although the importance and usage of NHEJ varies 
greatly among species (Karran, 2000). As NHEJ has no need for a DNA 
template, it can operate throughout the cell cycle, although it is thought to 
dominate DSB repair in the G1-phase of the cell cycle, where HRR activity is 
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1.5 Homologous Recombination Repair (HRR) 
HRR is a universal process for repairing DNA DSBs; it is highly conserved from 
bacteria to mammals and found in all forms of live. The fundamental 
characteristic of this pathway is that it requires a template DNA sequence 
homologous to the one which contains the DNA damage for an accurate 
restoration of the DNA molecule (Essers et al., 2000). This suggests that HRR 
in principle could occur in G1 phase as well, by using the homologous 
chromosome (Johnson and Jasin, 2000). However, it is thought that HRR is 
used preferentially in late S and G2 phase of the cell cycle taking advantage of 
the sister chromatid present (Krüger et al., 2004; Lee et al., 1997). In bacteria 
and yeast HRR is the main repair pathway despite the fact that HRR is a 
relatively slow but error-free process; its contribution in vertebrate cells remains 
uncertain. HRR may either repair only on a small fraction of DSBs, or may act in 
a process at a step after an initial end-joining by NHEJ (Iliakis et al., 2004). Yet, 
the evidence that HRR is functional in vertebrates is strong (Moynahan and 
Jasin, 2010). 
Homologous recombination is a versatile process utilized in several biological 
processes other than DSB repair. It is involved in meiotic cross over, which is 
responsible for the rearrangement of alleles in gametes. It is necessary for 
proper chromosome segregation and is important for mating type switching in 
yeast and epitope class switching in the majority of organisms. 
The process of HRR is schematically shown in Figure 5 and involves in principle 
the following steps: initial processing of DNA ends, search for homology, strand 
invasion into the intact homologous double helix and formation of Holiday 
junction, DNA synthesis with the associated branch migration, and final 
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al., 2007; Sartori et al., 2007; Takeda et al., 2007). The produced 3’ ss tails are 
recognized and bound first by the eukaryotic ssDNA binding replication protein 
A (RPA) to be protected from degradation and to avoid secondary structure 
formation (Sleeth et al., 2007; Wold, 1997). BRCA1 mediates the recruitment of 
BRCA2 to the DSB. BRCA2 is required for loading of Rad51 on RPA-coated 
ssDNA overhangs which is supported by the assistance of Rad51 paralogs. In 
yeasts Rad52 is thought to displace RPA and promote the binding of Rad51 to 
ssDNA, whereas in vertebrates this role is taken over by BRCA2. The Rad51 
nucleoprotein filament interacts with Rad54 and promotes searching for 
homology, unwinding of duplex DNA (Symington, 2002) and catalyzes strand 
invasion into the homologous duplex DNA. 
In the course of this process Rad51 is displacing the original strand of the 
duplex and forms a displacement loop (D-loop) by creating a Holiday junction 
(Baumann et al., 1996). The 3’-end of the invading strand primes for DNA 
synthesis of the template duplex and can be extended by branch migration. At 
the end of HRR, the predominant pathway appears to be synthesis-dependent 
strand annealing (SDSA), where the newly synthesized strand is reversed to 
anneal to the other original DNA end, resulting in a non-crossover outcome with 
no change to the template DNA. 
When a double Holiday junction is formed, a number of proteins are involved in 
resolving the D-loop and may function to mediate SDSA and to suppress 
crossovers. The main class are resolvases which functions in vitro are 
associated to human FANCM, metazoan RTEL1, mammalian RECQ1 and BLM, 
as well as to Rad54 (Heyer et al., 2010). It is still not known whether the final 
ligation step of the remaining nicks after disrupting D-loops is completed by 
DNA Ligase I (LIG1) and its interaction partner proliferating cell nuclear antigen 
(PCNA). Also Ligase III/XRCC1 (LIG3/XRCC1) could be implicated in this 
process. Alternatively resolvases themselves ligate and restore DNA integrity at 
the DNA ends. 
Consistent with the described intricacy of this pathway, HRR is a rather slow 
process. In yeast it takes up to 72 h to repair DSBs during the plateau phase of 




ability to restore the sequence around the DSB. The proteins involved in HRR 
are known to be expressed in the majority of mammalian cells and HRR have 
been confirmed in all organisms, from bacteria to yeast to human and the 
deficiency of HRR results in many organisms in embryonic lethality. Hence it is 
assumed HRR plays an important role in the removal of breaks, especially 
those arising from failures during DNA replication, although the real contribution 
to ionizing radiation induced DSB repair is only partially defined. 
1.6 Non-homologous End-joining (NHEJ) 
In cells of higher eukaryotes the predominant pathway to repair DSBs is thought 
to be NHEJ, which does not depend on extensive regions of homology (Jeggo, 
1998). It simply restores efficiently genome integrity by joining of two broken 
ends without ensuring restoration of the original sequence in the vicinity of the 
break (Lieber et al., 2003; Valerie and Povirk, 2003; Weterings and van Gent, 
2004). NHEJ enzymes are able to function on a diverse range of overhang 
variation, DNA end sequence, and DNA end chemistry and convert them to 
joined products with about the same efficiency in vivo.  
In general it requires enzymes to recognize breaks, a nuclease for processing 
the damaged end, DNA polymerases to synthesize and fill-in new DNA, and 
finally a ligation enzyme for subsequent restoration of DNA integrity (Lieber, 
2010). DNA-dependent protein kinase catalytic subunit (DNA-PKcs) and Ku are 
the key proteins to direct the end-joining to the DNA-PK dependent non-
homologous end-joining pathway (D-NHEJ) in a coordinated fashion (Perrault et 
al., 2004). There is evidence that cells of higher eukaryotes with defects in D-
NHEJ rejoin the majority of DSBs using an alternative repair pathway (Wang et 
al., 2003) that is not utilizing any of the HRR-associated activities (Iliakis et al., 
2004). This pathway is therefore termed backup NHEJ (B-NHEJ). 
The “multiple” discoveries in NHEJ repair led to a variety of terms which are 
used to describe it. To simplify differentiation between the two NHEJ pathways I 
will refer the frequently called canonical or classical NHEJ as D-NHEJ, since its 




(A-NHEJ, or alt-NHEJ) the term microhomology-mediated end-joining (MMEJ), 
Ku-independent end-joining, Ligase IV (LIG4)-independent NHEJ, and our 
proposed term backup NHEJ is used (Corneo et al., 2007; Liang et al., 2008; 
Ma et al., 2003; Wang et al., 2003). We prefer and I will use here the term 
B-NHEJ instead of A-NHEJ because this form of end-joining only comes to the 
fore when D-NHEJ is defective. Thus, it appears to operate as a “true” backup 
rather than an equal, alternative partner. However, it cannot be excluded that 
the failures during D-NHEJ repair, even in the presence of HRR, could lead to 
initiation of B-NHEJ activities. 
1.6.1 DNA-PK dependent non- homologous 
End-joining (D-NHEJ) 
D-NHEJ operates very efficiently in all phases of the cell cycle and is able to 
remove the majority of IR induced DSBs with very fast half times of 15–30 
minutes (Windhofer et al., 2007a).  
Like most of the DNA repair processes, D-NHEJ requires different steps and 
activities. Therefore a set of enzymes is needed for recognition of the break and 
holding the broken ends in proximity, a nuclease to resect damaged ends, a 
DNA polymerase to fill the gap with new DNA, and a DNA ligase to rejoin two 
ends and restoring DNA strand integrity. An outline of the in D-NHEJ involved 
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results in the activation of DNA-PKcs kinase activity (Walker et al., 2001). This 
enables phosphorylation of various proteins involved in this pathway including 
DNA-Pkcs itself. Several enzymes that are able to either remove or fill-in ssDNA 
regions or non-compatible overhangs have been identified. For instance, 
Artemis bound to DNA-PKcs functions as a endonuclease to allow 
end-resection of damaged overhangs (Ma et al., 2002). During this step of 
D-NHEJ, occasional loss of nucleotides is possible (Valerie and Povirk, 2003). 
Polymerase λ and μ are both able to bind Ku by the virtue of their BRCT 
domains and aid repair by catalyzing DNA polymerization. In the end of D-NHEJ 
a final ligation of the two ends occurs in a coordinated fashion by the 
LIG4/XRCC4 complex, which is also a phosphorylation target of DNA-PK (Leber 
et al., 1998), with its associated cofactor XLF (Ahnesorg et al., 2006). 
When the two ends from the same DSB are rejoined, integrity of the DNA 
molecule is restored. Each Ku bound to DNA end can function as an anchor 
where the nuclease, polymerase and ligase are able to accumulate. 
Recruitment of these enzymes can be performed in any order (Lieber, 2008; Ma 
et al., 2004). This flexibility displays the basis of the diverse outcomes from this 
pathway, where limited to extensive deletions or additions of nucleotides at the 
joined region arise (Lieber, 2010). 
In addition to the outlined proteins of HRR and D-NHEJ, numerous other 
proteins are involved as components of the process that signals the presence of 
damage in the DNA and activates the cellular responses to this damage. These 
proteins include Histone H1, phosphorylated histone H2AX, a variant form of 
histone H2A, and 53BP1. They all can be modified or can be translocated to 
specific nuclear locations in response to DNA damage induction. As a result 
they locate actual sites of DNA damage and their presence is indicative of 
ongoing DSB repair. Anyhow, defects in these proteins do not cause dramatic 
defects in DSB repair and cells have similar repair kinetics compared to those 
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The results of mutants with defects in Rad52 epistasis group of proteins 
involved in HRR displayed identical repair kinetics in PFGE experiments as wt 
cells. Furthermore, DT40 wt cells, despite their upregulated HR, show no 
difference in DSB repair kinetics and additional defects of D-NHEJ on top of 
HRR deficiency displayed no marked extra defect in DSB repair capability as 
measured by PFGE (Perrault et al., 2004). Thus, the residual end-joining 
activity cannot be attributed to HRR. 
Together, these results point to an alternative end-joining pathway in higher 
eukaryotes that operates with slower kinetics and mainly as a backup for 
D-NHEJ and is therefore termed B-NHEJ. This pathway is a distinct form of 
end-joining and is likely to be an evolutionarily older pathway with less 
optimized synapsis mechanisms that rejoins DNA ends with slower half-times of 
2 to10 h. It is anticipated that the rapid DNA end-joining of D-NHEJ kinetically 
suppresses the slower alternative pathway (Perrault et al., 2004).  
When D-NHEJ is chemically or genetically compromised, it contributes 
significantly to the overall repair, fixes the majority of breaks and restores 
genome integrity, albeit with increased probability for errors (Bennardo et al., 
2008; Iliakis et al., 2004). The slower kinetic and suboptimal synapsis 
mechanism gives more room and time for exchanges through the incorrect 
joining of DNA ends, leading to the formation of chromosomal aberrations 
during the repair of IR-induced DSBs. This observation places B-NHEJ at the 
center of carcinogenesis. 
Further investigations led to the discovery that alternative pathways of NHEJ 
are implicated in telomere maintenance (Rai et al., 2010), and can also robustly 
substitute for class switch recombination (CSR) (Soulas-Sprauel et al., 2007; 
Yan et al., 2007) and V(D)J recombination in D-NHEJ deficient cells (Corneo et 
al., 2007; Jones and Simkus, 2009; Lee et al., 2004). 
It was also found, albeit not as a necessary pathway requirement, that the use 
of microhomologies to some extend facilitates B-NHEJ. This characteristic led 
to a multitude of terms used for this repair pathways, like alternative NHEJ 
(A-NHEJ or alt-NHEJ) and microhomology-mediated end-joining (MMEJ), which 
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Hence, as a component of B-NHEJ, PARP1 might compete with Ku for DNA 
ends, where the much higher affinity of Ku for DNA ends provides a kinetic 
basis for the backup character of B-NHEJ (Wang et al., 2006). Another 
plausible cause for this backup character comes from the fact that the 
LIG3/XRCC1/PARP1 complex is also involved in other DNA repair activities, 
such as repair of SSBs and base damages, which are present in great excess 
in addition to DSBs and compete for PARP1 and furthermore for LIG3 
(Audebert et al., 2004; Wang et al., 2006). 
In addition to the function of Ku in the recruitment of DNA-PKcs some results 
strongly suggests that Ku may act as an alignment factor by transiently holding 
the DNA ends together, thus allowing the polymerase to prime DNA synthesis 
prior to ligation (Feldmann et al., 2000). 
Besides, there is evidence that histone H1, the MRN complex and Werner 
syndrome proteins (WRN) are involved in B-NHEJ since they are recruited to 
DSBs (Davies and Chen, 2010; Rosidi et al., 2008; Sallmyr et al., 2008). H1 
also helps to align DNA ends prior to ligation and enhances end-joining in vitro 
by LIG3 and LIG4 (Rosidi et al., 2008). Moreover, during V(D)J recombination, 
NBS1 is required for B-NHEJ of hairpin coding ends, whereas it shows a role in 
preventing B-NHEJ of signal ends and in coordinating four-ended inversional 
recombination events (Deriano et al., 2009). Since the inhibition of MRE11 in 
D-NHEJ mutants decreases end-joining frequency, the results suggest an 
essential function of MRN in B-NHEJ and that processing of DNA ends is a step 
in this repair pathway (Dinkelmann et al., 2009; Rass et al., 2009). In chronic 
myeloid leukemia (CML) cells, WRN is upregulated together with LIG3 and 
remodels under these conditions a complex to be recruited to DSBs (Sallmyr et 
al., 2008). 
Significantly, B-NHEJ has a marked dependence on growth state (Windhofer et 
al., 2007b). Whereas its activity is reduced in G1-phase cells and nearly 
abrogated in resting cells, it is markedly increased during the G2 phase of the 
cell cycle, suggesting that suppression of growth signaling significantly 




Despite the potential consequences of B-NHEJ function on genome integrity, 
little is known about the underlying molecular mechanisms, their regulation, 
integration into the cellular DSB processing apparatus, as well as their 
interaction with components of D-NHEJ and HRR. 
It is thus possible that in certain cases, even in repair proficient cells D-NHEJ 
fails somehow and thereby permits B-NHEJ to substitute for it. Likewise, DNA 
end-resection during B-NHEJ that generates single stranded DNA regions might 
facilitate the use of microhomology and may generate interdependencies with 
HRR. Since DNA end-processing and the use of homology is an important 
component of HRR, it would be of high interest to investigate to what extend 
irregular HRR events allow, or even initiate the function of B-NHEJ (Mladenov 
and Iliakis, 2011). 
1.7 DNA Ligases 
In the end of all DSB repair pathways, breaks in the phosphodiester backbone 
of the DNA are rejoined by DNA ligases. DNA Ligases are versatile enzymes 
and most organisms have multiple ligation enzymes that either function in DNA 
replication and join Okazaki fragments or are dedicated to particular DNA repair 
pathways, such as nucleotide excision repair (NER), base excision repair 
(BER), single strand break repair (SSBR), or the repair of DSBs via NHEJ 
(Shuman and Glickman, 2007; Tomkinson et al., 2006). Furthermore, breaks 
that are formed during the discontinuous DNA synthesis on the lagging strand 
of the replication fork and during recombination, are also rejoined by DNA 
ligases (Ellenberger and Tomkinson, 2008). By the feature of their enzymatic 
action DNA ligases are nucleotidyltransferases (NTases) that utilize ATP to 
catalyze the formation of a phosphodiester bonds by an a universal three 
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The NTase domain harbors the adenylate- binding pocket composed of six 
peptide motifs which display active-site residues. Motif I (KxDGxR) contains the 
conserved lysine to which AMP gets covalently linked in the first step of the 
ligation reaction. The amino acids (aa) of motifs I, Ia, III, IIIa, IV, and V just 
contact AMP and play essential roles in one or more steps of the ligation 
process. The OB-fold domain (OBD) consists of a five stranded antiparallel 
β-barrel plus an α-helix that assist the transfer of AMP to the active-site lysine of 
the NTase domain and subsequently undergo a large rotation, bind double 
stranded DNA and contact the 3’-OH and 5’-PO4 ends of DNA during the last 
two steps of ligation.  
Recent advances in the structure of DNA ligases reveal that all ligases except 
the simplest viral ligases completely encircle the DNA substrate using a 
multidomain architecture with sufficient flexibility to open and close around the 
DNA. Furthermore, rearrangements at the locus of the active site display an 
adaptive development throughout the multisteps of DNA ligation reaction. By 
extending this central core with different additional domains the different 
eukaryotic DNA ligase species have evolved functionally optimizing to 
completely encircle the DNA substrate. Besides, the unique regions flanking the 
conserved catalytic domain of eukaryotic ligases mediate protein-protein 
interactions and target each isoenzyme for a particular aspect of DNA 
metabolism and repair. 
Ligases of mammals own an additional N-terminal DNA-binding domain (DBD) 
that interacts with the minor groove and contacts the DNA upstream and 
downstream of the nick for efficient ligation activity. It stabilizes the DNA in an 
under wound conformation where the minor groove is enlarged, exposes the 
ligatable DNA ends and makes protein-protein interactions with the catalytic 
core forming a ring shaped structure that encircles the DNA (Cotner-Gohara et 
al., 2008; Pascal et al., 2004).  
The main characteristics of the DNA ligase proteins encoded by the genes 

















































































































































ion of the 




































 et al., 20
nes gene













































































































































































































 cells are 















































ll as to 
of BER 
ebrates 















Although the C-terminal extension of the catalytic region of DNA ligase IV 
contains two adjacent BRCT domains, LIG4 interacts with XRCC4 independent 
of phosphorylation (Critchlow et al., 1997; Grawunder et al., 1997) through an 
unusually long linker region. It mediates the contact between the two proteins 
by forming a distinct clamp structure of LIG4 that wraps around the linear 
XRCC4 tails to stabilize the interaction and become integrated in NHEJ 
pathway of DSB repair (to be termed here D-NHEJ) (Dore et al., 2006). D-NHEJ 
in vertebrates also comprises XLF, and the DNA dependent protein kinase 
(DNA-PK) complex, consisting of the Ku heterodimer and the catalytic subunit, 
DNA-PKcs. LIG4 is one of the targets of DNA-PK (Wang et al., 2004). Through 
this domain structure and possibly through adaptations in its central core, LIG4 
has the unique ability of joining DNA ends that are non-complementary (Gu et 
al., 2007). 
The predominant function of LIG4 in DSB repair is further supported by the 
phenotype of its inactivation in the mouse. Embryonic lethality occurs late, after 
multiple normal DNA replication cycles and is caused by massive apoptosis in 
the central nervous system (CNS) (Barnes et al., 1998; Frank et al., 1998; 
Frank et al., 2000). Life births are possible when CNS apoptosis is rescued by 
concomitant loss of either p53 or ATM function (Frank et al., 2000; Lee et al., 
2000; Sekiguchi et al., 2001), but LIG4-/-p53-/- MEFs are highly radiosensitive 
and show defects in DSB repair due to the D-NHEJ defect. 
Although LIG4 is firmly linked to D-NHEJ, it remains open whether it can 
substitute for the functions of other ligases. Also, the possible substitution of 
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key component of a NER subpathway that operates in dividing cells, but is 
particularly important for the repair of UV lesions in non-dividing cells (Moser et 
al., 2007). There is also evidence that LIG3 is a component of B-NHEJ (Wang 
et al., 2005). 
Although the confirmed specific functions of the peptides generated by the LIG3 
gene appear restricted to DNA repair, deletion of LIG3 has consequences 
significantly more severe than deletion of either LIG1 or LIG4 and causes early 
embryonic lethality that cannot be rescued by deletion of p53 (Puebla-Osorio et 
al., 2006). Whereas this result may be explained by the function of LIG3 in 
mitochondria DNA metabolism (Lakshmipathy and Campbell, 1999), or in BER 
and other repair pathways, this observation is intriguing and requires further in 
depth investigation. 
Because the LIG3 gene is only present in vertebrates, the use of genetically 
tractable lower eukaryotes, such as S. cerevisiae, to delineate their cellular 
functions is ruled out. Moreover, conclusions regarding the cellular functions of 
CDC9 and DNL4 genes, the yeast homologs of mammalian LIG1 and LIG4, 
cannot be extrapolated to mammalian cells because of their larger repertoire of 
DNA ligases that generates new ways of functional substitution. Finally, the 
nuclear and mitochondrial roles of LIG3 and LIG3 together with the lethal 
phenotype of LIG3 deletion generate urgent requirements for conditional gene 
targeting strategies. 
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2 Scope and aims of the work 
The genome of eukaryotic cells is under the continuous attack of deleterious 
environmental factors like cosmic and terrestrial radiation and of byproducts of 
the intracellular metabolism, such as reactive oxygen species and replication 
errors. They all can lead to the generation of DNA double strand breaks (DSBs), 
highly cytotoxic lesions, whose misrepair causes mutations and lethality. 
Biochemical and genetic studies support the view that the majority of DNA 
DSBs induced in the genome of higher eukaryotes by ionizing radiation (IR) are 
removed by two pathways of non-homologous end-joining (NHEJ) termed 
D-NHEJ and B-NHEJ. While D-NHEJ depends on the activities of the DNA-
dependent protein kinase (DNA-PK) and DNA ligase IV/XRCC4, B-NHEJ 
utilizes, at least partly, the DNA Ligase III/PARP-1/XRCC1 repair module and 
histone H1 as an alignment factor. 
DNA ligase III (LIG3) is, besides ligase I and IV, one of three known mammalian 
DNA ligases, and interestingly, it is restricted to vertebrates. Thus, genetically 
tractable lower eukaryotes such as S. cerevisiae cannot be used to delineate 
the functions of the LIG3 gene. 
The LIG3 gene of higher eukaryotes generates four distinct DNA ligase 
polypeptides in the form of nuclear and mitochondrial versions of DNA LIG3α 
and LIG3. The mitochondrial and nuclear versions of LIG3α are generated 
from LIG3α mRNA by an alternative translation initiation mechanism. The 
mitochondrial form is distinguished by an N-terminal mitochondrial targeting 
signal (MTS) that is proteolytically removed during transport into mitochondria. 
The N-terminal mitochondrial leader sequence is a unique characteristic of DNA 
LIG3 that is not shared by any of the other remaining ligases. Hence LIG3 is the 
only DNA ligase present in mammalian mitochondria participating in all 
important aspects of DNA metabolism including repair and replication of 
mitochondrial DNA. 
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The debate about backup pathways of NHEJ, which our laboratory started over 
ten years ago, is now a hot topic of DDR. Numerous studies suggest the 
alternative use of B-NHEJ whenever D-NHEJ is compromised.  
Thus, the overarching aim of this study was to define the functions of DNA 
ligases in B-NHEJ, especially of LIG3 and LIG1. Therefore we generated a 
series of knockout and knock-in mutants in the DT40 system in cooperation with 
Hiroshi Arakawa from Helmholtz Center Munich. While LIG1-/- and LIG4-/- 
mutants are viable and grow normally, LIG3 knockout is lethal. Therefore, 
conditional knockout models were developed and combined with knockouts of 
all other DNA ligases. 
The generated mutants and wild type (wt) cells were tested after induction of 
the conditional knockout of LIG3 by treatment with 4-hydroxytamoxifen (4HT) on 
their growth characteristics and survival, and with special emphasis the effect of 
LIG3 knockout induction on mitochondria function. In addition, real time PCR 
and an in vitro end-joining assay were used to define a timeframe after 4HT 
treatment where DSB repair experiments could be performed. 
DSB repair in the different mutants was measured in exponentially growing cells 
and measured using pulsed-field gel electrophoresis, colony formation assay 
and -H2AX foci formation and decay. Special emphasis was given to the 
mutants LIG1-/-LIG4-/- and LIG3-/-LIG4-/-mts-hLIG1, where the only remaining 
DNA ligase for DSB repair by B-NHEJ were LIG3 and LIG1, respectively. 
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3 Materials and Methods 
3.1 Materials 
Table 1: Laboratory Apparatus. 
Apparatus Provider 
Aluminum filter GE Healthcare, USA 
Cell counter, Multisizer™ 3 and 
Coulter Z2 
Beckman Coulter, Germany 
Centrifuge, AvantiTM J-20 XP Beckman Coulter, Germany 
Centrifugal elutriation rotor, JE-6 Beckman Coulter, Germany 
Centrifugal rotor, JA 25.50 Beckman Coulter, Germany 
Centrifuge, Rotana 460 R Hettich, Germany 
Cooling unit (external), DC10-K20 Thermo Fischer Scientific, Germany 
Dry Block Heater/Cooler HLC, Oehmen, Germany 
Electrophoresis chambers, Horizon 
11•14 and 20•25 
Life TechnologiesTM, USA 
Electrophoresis chamber, Mupid-One Advance Co. Ltd., Japan 
Electrophoresis Power Supply,  
EPS 301 
Amersham, GE Healthcare, USA  
FalconTM ExpressTM Pipet-Aid® BD Biosciences, Germany 
Flow cytometer, Epics XL and Gallios Beckman Coulter, Germany 
FluorImager, Typhoon 9400 Molecular Dynamics, Germany 
GloMax® 20/20 Luminometer Promega, Germany 
iBlot® Dry Blotting System Invitrogen, Life Technologies, 
Germany 
Inverted phase contrast microscope Olympus, Germany 
Laminar flow hood, HeraSafe Heraeus, Thermo Scientific, Germany
LC Carousel Centrifuge 2.0 Roche Diagnostics, Germany 
Licox CMP Oxygen Monitor Integra LifeSciences, Germany 
LightCyler 2.0 Roche Diagnostics, Germany 
Magnetic stirrer, MR Hei-Standard Heidolph, Germany 
MCO-18 O2/CO2 incubators Sanyo, Germany 
Metafer Slide Scanning Platform MetaSystems, Germany 
Metafer SlideFeeder MetaSystems, Germany 
Micro Centrifuge, IR Carl Roth, Germany 
NanoDropTM 2000 Thermo Scientific, Germany 
Nucleofector® 2b Device Amaxa, Lonza, Germany 
Odyssey® infrared imaging system LI-COR Biosciences, Germany 
Oxygen catheter microprobe, CC1SB Integra LifeSciences, Germany 
pH-Meter, FE20 – FiveEasy™ pH Mettler Toledo, Germany 
Pipettes, Pipet-LiteTM Mettler Toledo, Germany 
Power supply, PowerPacTM Basic Bio-Rad, Germany 
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PTB dosimeter Physikalisch-Technische 
Bundesanstalt, Germany 
Pump drive, MCP Standard Ismatec®, Idex Health & Science, 
Germany 
Pumphead, Easy-Load® II Ismatec®, Idex Health & Science, 
Germany 
SDS-PAGE apparatus Bio-Rad, Germany 
SDS-PAGE mini gels, Mini 
PROTEAN 
Bio-Rad, Germany 
Seifert Isovolt 320 HS X-ray tube Seifert, GE Measurement & Control, 
USA 
Rocky shaker Oehmen, Germany 
Tabletop centrifuge, Biofuge fresco  Heraeus, Thermo Scientific, Germany
Thermo-mixer Eppendorf, Germany 
Ultracentrifuge, Optima Max Beckman Coulter, Germany 
Ultracentrifuge rotor, MLN80 Beckman Coulter, Germany 
UV spectrophotometer Shimadzu, Germany 
Vacuum gas pump VWR, Germany 
Vortexer, IKA MS 3 basic IKA, Germany 
Water bath GFL, Germany 
Weighing balance, 572-43 Kern, Germany 
Weighing balance, VWR-124 Sartorius, Germany 
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Table 2: Disposable Products and Commercial Kits. 
Disposable Product /  
Commercial Kit 
Provider 
0.5, 1.5 and 2 ml reaction tubes Greiner, Germany 
2, 5, 10, 25 ml pipette Greiner, Germany 
3 mm diameter glass tubes CM Scientific Ltd., UK 
4.2 ml, 6.3 ml or 8 ml ultracentrifuge 
tubes 
Beckman 
12 ml non-cap tubes Greiner, Germany 
15 and 50 ml tubes Greiner, Germany 
20 mm glass cover slips Invitrogen, Life Technologies, 
Germany 
35 mm glass coverslip bottom dishes MatTek Corporation, USA 
60, 100 mm bacteria dishes Greiner, Germany 
150 mm culture dishes TPP, Switzerland 
CellTiter-Glo® Luminescent Cell 
Viability Assay 
Promega, Germany 
Cuvettes, Q-VETTES Halbmikro Ratiolab®, Germany 
Dialysis membrane, Spectra/Por® 
MWCO: 6-8,000 
Spectrum® Laboratories, USA 
ECL+ chemiluminescence detection 
Kit 
GE Healthcare, Germany 
Filter tips Greiner, Germany 
fluorescence microscope, AxioImager 
Z2 
Zeiss, Germany 
Glass flasks, beakers and cylinders Schott Duran, Germany 
High pure RNA isolation kit Roche Diagnostics, Germany 
ImmunoSelect® Adhesion Slides Squarix, Germany 
Maxima First strand cDNA Synthesis 
Kit 
Fermentas, Thermo Scientific, 
Germany 
Microscope Slides, H872 Carl Roth, Germany 
Minisart®, 0.45 µm sterile filter Sartorius, Germany 
MitoTracker® Green FM and Deep 
Red FM 
Invitrogen, Life Technologies, 
Germany 
NucleoBond Xtra Midi/Maxi Plus EF 
purification kit 
Macherey-Nagel, Germany 
NucleoSpin Tissue Kit Macherey-Nagel, Germany 
PAP pen for immunostaining Sigma-Aldrich, Germany 
Peha-soft® nitrile FINO gloves Hartmann, Germany 
Phase Lock Gel, 1.5 ml Heavy Eppendorf, Germany 
Pipettes Greiner, Germany 
Pipette tips Greiner, Germany 
LightCycler® capillaries Roche Diagnostics, Germany 
LightCycler® FastStart DNA 
MasterPLUS SYBR Green I Kit 
Roche Diagnostics, Germany 
iBlot® blotting stacks, Nitrocellulose 
and PVDF 
Invitrogen, Life Technologies, 
Germany 
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Table 3: Chemical Reagents 
Chemical Provider 
1,4 Dithiothreitol Carl Roth, Germany 
Agarose, LE Lonza, Germany 
Ampicillin Carl Roth, Germany 
ATP Sigma-Aldrich, Germany 
β-Mercaptoethanol Sigma-Aldrich, Germany 
Blasticidin S InvivoGen, Germany 
Boric acid Carl Roth, Germany 
Bovine serum albumin fraction IV Carl Roth, Germany 
Bromophenol blue Sigma-Aldrich, Steinheim, Germany 
Caspase Inhibitor III, BOC-D-FMK Calbiochem®, Merck Millipore, 
Germany 
Chicken serum Gibco®, Life Technologies, Germany 
Chloramphenicol Carl Roth, Germany 
Chloroform Sigma-Aldrich, Germany 
Coomassie brilliant blue R 250 SERVA, Germany 
Crystal violet Merck, Germany 
CsCl Crescent Chemical, USA 
DAPI Sigma-Aldrich, Germany 
Dimethyl sulfoxide Sigma-Aldrich, Germany 
Dulbecco's Modified Eagle Medium: 
Nutrient Mixture F-12 
Gibco®, Life Technologies, Germany 
Ethanol Sigma-Aldrich, Germany 
Ethidium bromide Roth, Germany 
EDTA Roth, Germany 
Fetal bovine serum Biochrom, Germany; 
PAA, Coelbe, Germany; 
Gibco®, Life Technologies, Germany 
G418 InvivoGen, Germany 
Gelatin Calbiochem®, Merck Millipore, 
Germany 
GeneRulerTM 1 kb DNA Ladder Fermentas, Thermo Scientific, 
Germany 
GeneRulerTM 100 bp Plus DNA 
Ladder 
Fermentas, Thermo Scientific, 
Germany 
Glycerol Carl Roth, Germany 
GlutaMAXTM Gibco®, Life Technologies, Germany 
HCl Carl Roth, Germany 
HEPES Carl Roth, Germany 
LB agar USB ®, Affymetrix ®, USA 
LB medium USB ®, Affymetrix ®, USA 
KCl Carl Roth, Germany 
KH2PO4 Carl Roth, Germany 
KOH Carl Roth, Germany 
Low melting agarose Carl Roth, Germany 
Lysozyme Sigma-Aldrich, Germany 
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Methanol Sigma-Aldrich, Germany 
Methylcellulose Sigma-Aldrich, Germany 
MgCl2 Merck, Darmstadt, Germany 
Minimum Essential Medium Gibco®, Life Technologies, Germany 
NaCl Carl Roth, Germany 
NaF Carl Roth, Germany 
NaHCO3 Carl Roth, Germany 
NaH2PO4 Merck Millipore, Germany 
Na2HPO4 Carl Roth, Germany 
NLS Merck, Heidelberg, Germany 
Non-fat dry milk Carl Roth, Germany 
NotI Fermentas, Thermo Scientific, 
Germany 
NU7441, KU-57788 Tocris Bioscience, USA 
Orange G Carl Roth, Germany 
Paraformaldehyde Carl Roth, Germany 
Phenol Carl Roth, Germany 
Phosphoric acid Carl Roth, Germany 
Phenylmethylsulfonyl fluoride Carl Roth, Germany y 
Poly-L-lysine Biochrom AG, Berlin, Germany 
Primer Invitrogen, Germany 
ProLong® Gold antifade reagent Invitrogen, Germany 
Propidium iodide Sigma-Aldrich, Germany 
Protease, from Streptomyces griseus Sigma-Aldrich, Germany 
Puromycin InvivoGen, Germany 
RIPA buffer Thermo Scientific, Germany 
RNase A Sigma-Aldrich, Germany 
Rotiphorese® Gel 30 (37.5:1) Carl Roth, Germany 
Page Ruler, Prestained Protein 
Ladder 
Fermentas, Thermo Scientific, 
Germany 
SalI Promega, Germany 
Fermentas, Thermo Scientific, 
Germany 
Sodium dodecyl sulfate Carl Roth, Germany 
Streptomycin Calbiochem®, Merck Millipore, 
Germany 
Sucrose Sigma-Aldrich, Germany 
SYBR Gold Molecular Probes, Life Technologies, 
Germany 
Tetramethylethylenediamine (TeMeD) Sigma-Aldrich, Germany 
Tris base Carl Roth, Germany 
Triton X-100 Sigma-Aldrich, Germany 
Trypsin Biochrom, Germany 
Tween 20 Carl Roth, Germany 
Xylene Cyanol Sigma-Aldrich, Germany 
 




3.2.1 Cell culture 
DT40 cells are suspension cells and were grown in D-MEM/F12 supplemented 
with 10% fetal bovine serum (FBS), 1% chicken serum, 50 µM -
mercaptoethanol (β-ME) at 41ºC in a humidified SANYO MCO-18 O2/CO2 
incubator with 5% CO2 and 95% air. Cells were grown in 100 mm bacteria 
dishes with 10 ml growth medium and maintained in the logarithmic phase of 
growth through routine passaging by dilution with fresh medium. 
When frozen stocks of cells were taken to subculture, they were passaged at 
least two times before being used in experiments and were discarded after 
approximately one month or about 40 passages. In all experiments 
exponentially growing cells were used unless otherwise indicated. The 
distribution of cells throughout the cell cycle was routinely measured by flow 
cytometry. 
 
3.2.2 Drug treatments 
All inhibitors used were dissolved in dimethyl sulfoxide (DMSO), and were 
applied to culture medium 1 h before irradiation unless otherwise indicated. 
Table 4 lists all inhibitors with their mechanism of action and the concentrations 
used. 
Table 4: Used inhibitors with mode of action and final concentrations 
Drug Description Final Concentration
Caspase Inhibitor III 
(BOC-D-FMK) 
A synthetic peptide that 
irreversibly inhibits activity of 
caspase family proteases and 
blocks apoptosis 
100 µM 
NU7441 (KU-57788) Highly potent and selective 
DNA-PK inhibitor 
10 µM 
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3.2.3 Parental Cell line 
Mutants analyzed here were derived from the DT40-Cre1 cell line. The primary 
DT40 cell line was established in the laboratory of Eric. H. Humphries from an 
Avian Leukosis Virus (ALV) induced B cell lymphoma in the Bursa of Fabricius 
from a female White Leghorn chicken (Baba et al., 1985) and derived its official 
name LSCC-DT40 due to the proposed unified designation system for avian 
tumor transplants and cell lines (Witter et al., 1979). 
The DT40-Cre1 cell line used here conditionally express Cre recombinase to 
allow genome editing, and v-myb to enhance gene conversion (Arakawa et al., 
2012; Arakawa et al., 2002; Arakawa et al., 2001). Cre recombinase is 
expressed from a human β-actin promoter as a chimera, MerCreMer, between a 
mutated estrogen receptor (Mer), only responding to 4HT (Zhang et al., 1996), 
and Cre recombinase (Arakawa et al., 2002; Arakawa et al., 2001). In the 
absence of 4HT, MerCreMer is efficiently sequestered by heat shock proteins in 
the cytoplasm. This interaction is rapidly disrupted upon administration of 4HT 
and causes the translocation of the protein to the nucleus, where Cre exerts 
recombination activity at loxP sites. Cells are also AID-/- and carry a deletion in 
the pseudo V locus of the non-rearranged Ig light chain locus. Furthermore, the 
non-rearranged V-intervening-sequence is replaced by a rearranged VL light 
chain gene together with DsRed as a hypermutation reporter. Thus, the full 
description of the parental cell line is DT40-AID-/-IgLdual; and is referred here as 
DT40 (Arakawa et al., 2012). 
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3.2.4 Targeting strategies and mutants 
While LIG4 is solidly implicated in the D-NHEJ pathway of DSB repair, the 
responsible ligase for B-NHEJ is less well characterized. Early work from our 
laboratory, as well from the laboratories of other investigators, provides strong 
biochemical evidence for the putative involvement of LIG3 in B-NHEJ. However, 
the biological significance of these observations remains less well 
characterized. To investigate the individual functions and possible functional 
overlap among DNA ligases, we developed in a higher eukaryotic cell system a 
comprehensive gene targeting strategy to study the ligation requirements of 
DNA replication and repair (Arakawa et al., 2002; Arakawa et al., 2004). For this 
study the majority of mutant was generated at the Institute for Molecular 
Radiobiology, Helmholtz Center Munich by Dr. Arakawa and they were 
functionally characterized for their DSB repair ability as part of the present work. 
Mutants generated in Essen are mentioned explicitly. 
Since the LIG3 gene has not been described in DT40, we started with a 
phylogenetic tree analysis of the ligase genes using the neighbor joining 
method and organisms for which sequences were available. While LIG1 and 
LIG4 can be detected in all eukaryotes from yeast to plants and animals, LIG3 
is only found in vertebrates, including the chicken. Surprisingly, our homology 
search uncovered a previously undetected LIG3 homolog in Drosophila. 
Notably, despite extensive homology search, we were unable to identify in 
higher eukaryotes including the chicken, genes of the DNA ligase family, other 
than LIG1, LIG3 and LIG4. 
The six amino acids of the active site are highly conserved across species 
including the bacteriophage T4, emphasizing its importance in enzyme activity. 
In an effort to minimize the risk of residual activity, we constructed targeting 
vectors deleting a substantial portion of the core region including the enzyme 
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5’-half of the catalytic core including the enzyme active site. Follow up of locus 
editing by PCR shows excision of the drug resistance cassette 8 h after addition 
of 4HT and of the floxed LIG3 exons within 4-8 h (Arakawa et al., 2012).  
In the conditional LIG3+/2loxP cells, the second allele is targeted with the vector 
pLig3Gpt deleting a segment from the middle of exon 4 up to exon 10 and 
inserting an in-frame stop codon into exon 3, as well as the xanthine-guanine 
phosphoribosyl transferase (gpt) resistance cassette. This cassette is 
subsequently excised by limited Cre induction with 4HT. In this way, the mutant 
LIG3-/2loxP is generated in which the conditional LIG3 allele can be excised upon 
further treatment with 4HT (Arakawa et al., 2012; Paul et al., 2013). 
In addition to the above nuclear form of LIG3, the mitochondria form made from 
the same mRNA supports replication and repair of the mitochondria DNA. In an 
effort to separate the nuclear and mitochondrial functions of LIG3, we 
inactivated the M2 translation initiation site in the second allele of the LIG3+/2loxP 
mutant using the targeting vector pLig3M2IBsr. The vector introduces an 
inactivating mutation in the M2, while preserving M1, translation initiation site. 
Following excision of the bsr drug resistance cassette from the second allele, a 
mutant is generated expressing constitutively only the mitochondrial form of 
LIG3 (LIG3-/M2I) (Paul et al., 2013). 
 
3.2.4.2 Targeting of LIG1 
Conditional targeting strategies similar to those described for LIG3 were also 
employed for LIG1 to account for the possibility that the LIG1 knockout is lethal 
as well (Arakawa et al., 2012). In the bursal cDNA database, we identified an 
incomplete chicken LIG1 cDNA sequence encoding the 658 C-terminal amino 
acids. The amino acid sequence of chicken LIG1 derived from this cDNA 
shared 66% identity and 81% similarity with the human enzyme. Therefore, we 
deduced the numbering of amino acids and exons of the entire chicken LIG1 
locus from that of human and used it to construct appropriate targeting vectors. 
The first LIG1 allele was targeted using the vector pLig1Lox3Bsr containing the 
LIG1 exons 12-28 and the bsr drug resistance cassette, in addition to the three 
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loxP sites. This allowed the generation of the conditional mutant LIG1+/2loxP. The 
second LIG1 allele was disrupted with the pLig1Puro targeting vector, which 
deletes the same LIG1 region and generates the LIG1-/2loxP mutant. Treatment 
of this mutant with 4HT deletes exons 17-28 and generates a truncated LIG1 
lacking amino acids 509-919, which cover the entire catalytic core including the 
enzyme active site (red bar in Figure 16). 4HT-induced locus-editing reactions 
were confirmed also for this ligase by PCR (Arakawa et al., 2012). 
 
3.2.4.3 Targeting of LIG4 
For the inactivation of LIG4 we employed a conventional knockout strategy 
(Arakawa et al., 2012). The amino acid sequence of chicken LIG4 has 75% 
identity and 85% similarity with the human enzyme. The chicken LIG4 gene 
does not contain introns and is composed of a single exon. The vector pLig4Bsr 
was therefore designed to delete the entire coding sequence of one LIG4 allele, 
while allowing at the same time recycling of the selection marker. The vector 
pLig4Puro4 was designed to delete amino acids 185-614 of the second allele 
while inserting an in frame stop codon after codon 184. Integration of this vector 
deletes the entire catalytic core including the LIG4 active site. The latter vector 
also allowed recycling of the selection marker. Successive targeting and the 
selection-marker-recycling steps were again confirmed by PCR reactions 
(Arakawa et al., 2012). 
 
3.2.4.4 Targeted integration of overexpression vectors 
In case of targeted integration of overexpression vectors we wanted to ensure 
consistent expression of transgenes and constructed the expression vector, 
pChr8RsvLoxIresBsr, which can be targeted into a defined intergenic locus on 
chromosome 8, as previously described (Arakawa et al., 2012; Paul et al., 
2013). The vector integrates without destroying or grossly disturbing nearby 
genes. Transgene expression is driven by the Rous sarcoma virus (RSV) 
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promoter and is followed by an internal ribosome binding site (IRES), the bsr 
selection marker and the SV40 polyA signal. The yeast LIG1 homolog, CDC9 
and the human LIG1 with a mitochondrial leader sequence (mts-hLIG1) genes 
were cloned into this vector and knocked into DT40 (Arakawa et al., 2012; Paul 
et al., 2013). 
 
3.2.4.5 Synopsis of the generated mutants 
For a conclusive elucidation of the contributions of LIG1 and LIG3 to DSB 
repair, we generated a large set of knockout and knock-in mutants in chicken 
DT40 cells. This set of mutants (summarized in Table 5) includes, in addition to 
knockouts for individual DNA ligases, also double and triple ligase knockout 
mutants, as well as ligase knock-in mutants in appropriately selected genetic 
backgrounds (Paul et al., 2013). 
Table 5: A summary of the key features of knockout, conditional knockout and knockin 
DT40 mutants used in the present study (Paul et al., 2013). 
Cell line Feature 
LIG1-/-  LIG1 knockout 
LIG3-/2loxP  LIG3 conditional knockout 
LIG3-/- * LIG3 knockout 
LIG3-/M2I  nuclear LIG3 knockout 
LIG4-/-  LIG4 knockout 
LIG1-/-LIG4-/-  LIG1 knockout; LIG4 knockout 
LIG3-/2loxPLIG4-/-  LIG3 conditional knockout; LIG4 knockout 
LIG3-/-LIG4-/- * LIG3 knockout; LIG4 knockout 
LIG3-/M2ILIG4-/-  nuclear LIG3 knockout; LIG4 knockout 
LIG3-/-Cdc9  LIG3 knockout overexpressing CDC9 (yeast LIG1) 
LIG3-/2loxPLIG4-/-mts-hLIG1 + LIG3 conditional knockout; LIG4 knockout 
overexpressing human mitochondrial LIG1 
LIG3-/-LIG4-/-mts-hLIG1 * + LIG3 knockout; LIG4 knockout overexpressing 
human mitochondrial LIG1 
* Deletion of the conditional allele by treatment of the parental cell line with 4HT. Note, 
not all of the generated mutants are viable. 
 Mutants generated by H. Arakawa. 
+ Mutants generated by K. Paul.  
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3.2.5 Cell transfection by electroporation 
To generate the above describe mutants two methods of electroporation were 
used to introduce vector DNA into DT40 cells. (Paul et al., 2013). In the first 
protocol, electroporation was carried out with cells suspended in complete 
growth medium. 107 cells were electroporated using the GenePulser-Xcell 
(BIORAD) at 25 µF and 700 V. In the second protocol, 106 cells were 
electroporated in an Amaxa cuvette with program 21 in Buffer B using 
Nucleofector® II device (Amaxa).  
After transfection cells were placed in prewarmed medium and subcloned by 
limiting dilution in 96 well flat bottom microtiter plates. Therefore, 10 ml medium 
containing an appropriate number of cells were prepared and 100 µl cell 
suspension was added to each well of the plate. After 24h 100 µl growth 
medium with the corresponding selection drug was added. Stable transfectants 
were selected in 15 µg/ml of blasticidin S, 1 µg/ml mycophenolic acid, or 1 
µg/ml of puromycin, as appropriate. After 8 to 10 incubation days subclones 
were visible as round colonies and were picked from the plate. Targeted clones 
were screened by PCR (Paul et al., 2013). 
 
3.2.6 Validation of ligase knockouts by PCR 
Targeted integration events were screened by polymerase chain reaction (PCR) 
using primer located upstream of the 5’ targeting arm of the construct together 
with a primer from the resistance marker as previously described (Arakawa et 
al., 2002; Paul et al., 2013). For this purpose, genomic DNA was isolated 
according to the protocol using NucleoSpin Tissue Kit (Macherey-Nagel). DNA 
concentration was determined with a spectrophotometer (NanoDrop; Thermo 
Scientific). 
PCR reactions were performed with 50 ng of genomic DNA and an appropriate 
primer pair using Expand-Long-Template PCR System (Roche) according to the 
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protocol of the manufactor. The available primers for PCR screening are 
summarized in Table 6. 




1LI19 CCCCCTTCTACCCCAAATCCTGATAATTTT For 
1LI35 GACAGTGTTGGTGGGATGACACAGGGATCC For 
1LI37 TTTGTAGTCTGCTAGTAAGAAGATTGACAT For 
1LI47 GGGACTAGTTGGTAGGGGCAGTTAGTGCTAGGCT Rev 
1LI5 TCCCGGTGCTGCTGGAGCATGGCCTGGA For 
1LI8 TTGTACTCGCAGGTGAATGCAGCCTCCTCA Rev 
3LI32 GGTTCATGTCTGCAATTAAGTAAAAGTAGC For 
3LI32R GCTACTTTTACTTAATTGCAGACATGAACC Rev 
3LI34 TTAGCACCAGAATCAGACTTGGAGAGAAAT For 
3LI41 CAACTGCAACATCTAAACTAGTGGAT Rev 
3LI44 CATCCCTCTGCCTGTGCACACGTGGCTGTG For 
3LI62 GGACAGCAAGCAGCCTCCAAGCGGACTGAG For 
4LI18 TGCTTCATCTCTGCCTGAAAGACAATTTCA For 
4LI34 CGGCTGCGCGCGGCGGTTCTTTTCCGACTC For 
4LI39 CTGGATGGTGAACGTATGCAGATGCACAAA For 
4LI40 AATACATCAAACACACAGAAGCAGGTCTGC Rev 
ML29 GGCTAGCGAATTCATAACTTCGTATAGCAT Rev 
BS1 CGATTGAAGAACTCATTCCACTCAAATATACCC Rev 
GP1 TGTTGATATCCCGCAAGATACCTGGATTGA Rev 
PU5 CCCACCGACTCTAGAGGATCATAATCAGCC Rev 
RS16 TGTAGCTTAAATTTTGCTCGCGCACTACTC Rev 
CHR0807 AGATGTGCCCTGGGACAAAGATTCTGGCCA For 
CHR0806 ACGTGTGTCCCATTAGGCAAAACCTTGAGA For 
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PCR was performed with the PCR protocol shown in Table 7.  
Table 7: PCR protocol for screening of targeted integration. 
Temperature Time Cycles PCR step 
94°C 240 s 1 Initial Denaturation 
94°C 10 s 
35 
Denaturation 
65°C 30 s Annealing 
68°C 90 s Extension 
68°C 420 s 1 Terminal Extension 
4°C hold  Cooling 
 
Reactions were monitored by loading 10 µl of a reaction mixed with 6 x DNA 
loading buffer (6 x DLB) on an 1% agarose gel. Gel run was performed for 40 
min at 100 V with Mupid®-One electrophoresis system (Advance Co. Ltd.). Gels 
were stained for 30 min in 0.5 x TBE containing 2 µg/ml Ethidium bromide 
(EtBr) and scanned with a FluorImager (Typhoon, Molecular Dynamics). 
 
3.2.7 Reverse transcription and RT-PCR 
Relative expression levels of DNA ligases were measured by real-time 
polymerase chain reaction (RT-PCR) as recently described (Arakawa et al., 
2012; Paul et al., 2013). Therefore, RNA was prepared according to the 
protocol of the High Pure RNA Isolation Kit (Roche) with the exception that 
three million cells were used for total RNA isolation. RNA concentration was 
determined with a spectrophotometer (NanoDrop; Thermo Scientific).  
cDNA was prepared from 1 µg total RNA by reverse transcription using the 
Transcriptor First Strand cDNA Synthesis Kit (Roche) according to the 
manufacturer’s instructions. This cDNA was used as input in real-time PCR 
reactions. 
Realtime-PCR was performed according to the protocol suggested in the 
LightCycler® FastStart DNA MasterPLUS SYBR Green I kit (Roche). Briefly, 1 µl 
of cDNA, 0.5 µl of sense and antisense primer solution, 2 µl of LightCycler® 
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FastStart DNA MasterPLUS SYBR Green I Master Mix and 6 µl H2O were mixed 
together in a 10 µl reaction mixture and put in a LightCycler® Capillary. Glass 
capillaries were placed in the sample carousel of the LightCycler® (Roche). The 
settings for the thermal cycles are listed in Table 8 with a following melting 
curve analysis by increasing the temperature and continuous fluorescence 
signal measurement. 
Table 8: Real-time PCR protocol to measure DNA ligase gene exression. 
Temperature Time Cycles PCR step 
95°C 600 s 1 Initial Denaturation 
95°C 10 s 
45 
Denaturation 
62°C 5 s Annealing 
72°C 10 s Extension 
65°C – 95°C 0.1°C/s  Melting Curves 
37°C 30 s  Cooling 
 
The used primer sequences for the different DNA ligases and the utilized 
Housekeeping gene (HKG) TATA-binding protein 1 (TBP1) are listed in Table 9. 
Table 9: Summary of the primer sequences used for real-time PCR. 
Oligo nucleotide Sequence 
Chk TBP1-F CAGCACCAACAGTCTGTCCA 
Chk TBP1-R GGGGCTGTGGTAAGAGTCTG 
Chk Lig1-F7 CATCTGCAAGATAGGCACTG 
Chk Lig1-R7 CCCAAATCGTCACCAAACAG 
Chk Lig3-F GATGACCCCAGTTCAGCCTA 
Chk Lig3-R GTGGGCTACTTTGTGGGGAA 
Chk Lig4-F CCCCATTAACAGGCAGGATA 
Chk Lig4-R CCACGTTTGTCAGGCTTGTA 
Lig1 Hs F1 GAATTCTGACGCCAACATGCA 
Lig1 Hs R1 CCGTCTCTCTGCTGCTATTGGA 
Lig1 Hs F2 CAGAGGCCAGAAAGACGTG 
Lig1 Hs R2 GTCCAGGTCGGGAACCTC 
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3.2.8 Analysis of cell cycle distribution by flow 
cytometry 
Flow cytometry allows measurement of several different cellular parameters as 
well as cell sorting on the basis of different properties by assessing 
fluorescence intensity. This technique is also termed as fluorescence activated 
cell sorting (FACS). For instance, cell cycle distribution can be evaluated by 
measuring fluorescence intensity of propidium iodide (PI) bound to DNA, as PI 
binds to DNA proportionally to its mass. Hence, the fluorescence intensity of PI 
is proportional to the DNA amount present in a cell. As after replication the DNA 
amount is doubled, there is twice as much signal generated from a G2-phase 
cell as compared to G1-phase cell. In this way, it is possible to distinguish cells 
in different phases of the cell cycle by their detected DNA amount. 
Therefore cells were collected by centrifugation and either fixed in 70% ice cold 
ethanol for at least 15 min or directly stained. Ethanol fixed cells were spun 
down at 1500 rpm for 5 min and were resuspended in 1x phosphate-buffered 
saline (PBS; 1.37 M NaCl, 27 mM KCl, 74 mM Na2HPO4, 15 mM KH2PO4, 
pH 7.4) containing 40 µg/ml propidium iodide (stock 4 mg/ml in water) and 
62 µg/ml RNase A (stock 6.2 mg/ml in 10 mM Tris, 100 mM EDTA, 50mM NaCl, 
pH 7.6). Cells were incubated at 37ºC for 20 min or at room temperature for 
45 min. Unfixed cells were spun down at 1500 rpm for 5 min and were 
resuspended in buffer for PI-staining without fixation (100 mM Tris pH 7.0, 
100 mM NaCl, 5 mM MgCl2, 0.05% Triton X-100) containing also 40 µg/ml PI 
and 62 µg/ml RNase A and stained at room temperature for 10 min. 
Measurements of cell cycle distribution were carried out with an Epics XL-MCL 
(Beckman-Coulter) flow cytometer. During the measurements the cells are 
suspended within the flow cytometer with Isoton II (135 mM NaCl, 13 mM 
Na2HPO4, 1 mM EDTA, 5 mM KCl, 1.45 mM NaH2PO4·H2O, 7 mM NaF, pH 7.4) 
to obtain a stream of fluid sheath with single cells. For each sample 10,000 to 
20,000 cells were counted and the single cell population was gated to obtain 
standard histograms. Histogram files (*.HST) were generated by counting the 
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3.2.10 Measurement of Oxygen Consumption 
The amount of oxygen consumed by cells is an indicator of their metabolic rate. 
As mitochondrial function is responsible for the majority of oxygen consumption 
within the cell, about 70–90%, any reduction in mitochondrial function can 
therefore have a major effect upon total oxygen utilization (Chen et al., 2009). 
The oxygen consumption in DT40 cell suspensions was measured with an 
oxygen electrode (Oxygen catheter microprobe (CC1SB) attached to a Licox 
CMP Oxygen Monitor (Integra LifeSciences) in an enclosed glass chamber. 
Before use, cells were suspended in fresh preheated growth medium at a 
concentration of 5 x 106 cells/ml. During the measurement cells were 
maintained in a water bath at 41°C and the relative change in oxygen 
concentration in the glass chamber was manually recorded every 5 min for up 
to 1 h. 
 
3.2.11 Analysis of mitochondria integrity 
To investigate mitochondria integrity in DT40, the MitoTracker Green probe 
(Invitrogen) was used. MitoTracker Green FM is green-fluorescent 
mitochondrial stain which appears to localize to mitochondria regardless of 
mitochondrial membrane potential (Invitrogen). Cells from standard cultures 
were directly stained with 100 nM MitoTracker Green for 30 min at 41°C. Cells 
were analyzed in an Epics XL-MCL (Beckman-Coulter) flow cytometer after 
centrifugation and resuspension in PBS. 
  
Materials and Methods 
70 
 
3.2.12 Measurement of Apoptotic index 
The appearance of cell death is often defined by morphological criteria, 
whereas pyknosis, or karyopyknosis, followed by karyorrhexis, or fragmentation, 
is the irreversible condensation of chromatin in the nucleus of a cell undergoing 
apoptosis. To determine the Apoptotic Index of a sample cells were collected by 
centrifugation and fixed in 70% ethanol. Ethanol fixed cells were resuspended in 
4',6-diamidino-2-phenylindole (DAPI) staining solution (0.1 M Tris, pH 7.0, 0.1 M 
NaCl, 5 mM MgCl2, 0.05% Triton X-100 and 2 µg/ml DAPI). After incubation for 
5 min, an aliquot was analyzed under a fluorescent microscope by counting the 
fraction of pycnotic and fragmented nuclei within 1000 cells. 
 
3.2.13 Cell fractionation in the different phases of the 
cell cycle by centrifugal elutriation 
Cell populations enriched in G1- or G2-phases of the cell cycle were obtained 
by centrifugal elutriation – a method for isolating cellular subpopulations on the 
basis of their sedimentation coefficient (Arakawa et al., 2012; Paul et al., 2013). 
For elutriation, cells were grown for 24h from a concentration appropriately 
selected to be exponentially growing and reach approximately 1.5 x 106 
cells/ml. Cells (2-3 x 108) were collected and elutriated at 4°C using a Beckman 
JE-6 elutriation rotor and a Beckman J2-21M high-speed centrifuge at a flow of 
25 ml/min with medium containing 1% FBS (Beckman, Krefeld, Germany). Cells 
were loaded at 4,100 rpm, and 250 ml fractions collected between 3,300 and 
2,200 rpm at 100-rpm steps. Cells were then sequentially elutriated out of the 
rotor based on their size, with small ones coming out first. In an exponentially 
growing culture, cell size approximates phases of the cell cycle, with G1-phase 
cells being small and G2-phase cells being large. Cell-cycle analysis was 
carried out by flow cytometry for unfixed cells as described above. Usually 
fractions of highly enriched cells in G1 and G2 cells were used for experiments. 
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3.2.14 Irradiation of cells 
For irradiation experiments regularly exponentially growing cells were used. 
Since DT40 cells are suspension cells they were irradiated in 60 mm petri 
dishes in suspension with culture medium. With synchronized cells, enriched 
cells were resuspended to 2 x 106 cells/ml in fresh growth medium prior to 
irradiation and were processed as described for exponentially growing cells. 
X-rays were generated by an X-ray machine (“Isovolt 320HS”, Seifert/Pantak, 
General Electric-Pantak) with an effective photon energy of approximately 
90 keV. The machine was operated at 320 kV and 10 mA using a 1.65 mm 
aluminum (Al) filter (GE-Healthcare) to absorb soft X-rays. Dosimetry was 
performed with a PTB dosimeter (Physikalisch-Technische Bundesanstalt, 
Braunschweig, Germany) that was used to calibrate an in-field ionization 
monitor. Radiation dose was monthly confirmed with Fricke’s chemical 
dosimetry (Frankenberg, 1969). Cells were exposed to X-rays in petri dishes at 
a distance of 50 cm to the source at a dose rate of approximately 2 Gy/min and 
even irradiation was ensured by rotating the radiation table. Immediately after 
IR exposure cells were returned to the incubator, and at different repair times 
collected according to the experimental procedure. Unirradiated control cells 
were treated similarly (sham-irradiated). 
3.2.15 Colony Formation Assay 
Cell radiosensitivity to killing was determined by their clonogenic survival in the 
colony formation assay as previously described (Arakawa et al., 2012; Paul et 
al., 2013). Because DT40 are suspension cells, it is necessary to restrict their 
movement during the incubation time by seeding them in a viscous growth 
medium containing 1.5% methylcellulose (MC). Cells are plated in 5 ml 
MC-medium in dilutions aiming at 100 – 200 colonies per dish and incubated for 
10-14 d in a humidified SANYO MCO-18 O2/CO2 incubator with 5% CO2 and 
95% air. Colonies are counted without any staining using a reflected-light 
microscope. 
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3.2.16 Pulsed-field gel electrophoresis (PFGE) 
Asymmetric field inversion gel electrophoresis, a pulsed field gel electrophoresis 
(PFGE) technique, was developed by Stamato and Denko in 1990 (Stamato 
and Denko, 1990) and is a specific technique to measure IR-induced DSBs in 
genomes of cells of higher eukaryotes. This technique takes advantage of the 
fact that fragmentation of chromosomal DNA by radiation leads to a linear and 
dose dependent increase in the fraction of DNA that enters the gel, whereas 
intact mammalian chromosomes are unable to do so. As recently described in 
detail (Paul et al., 2013), PFGE resolves DNA fragments ranging in size from 
0.2-6 Mbp, and detects damage induced by as little as 2 Gy of X-rays, whereas 
gel electrophoresis with a constant electric field cannot resolve DNA fragments 
much above 50 kbp. 
To evaluate induction of DSBs at different radiation doses (i.e. dose response 
experiment) cells were resuspended in cold serum-free medium, and mixed with 
an equal volume of pre-warmed (50°C) serum-free medium containing 1% low 
melting agarose to reach a final concentration of 7 x 106 cells/ml. The 
cell-agarose suspension was then pipetted into glass tubes with a diameter of 3 
mm and placed on ice to allow solidification. Solidified cell-agarose suspension 
was extruded from glass tubes and cut into 5 mm long cylindrical pieces (plugs) 
containing approximately 175 x 103 cells/plug. Subsequently, agarose plugs 
were placed in a 60 mm petri dish containing 3ml cold serum-free medium and 
exposed to different X-ray doses on ice. Plugs were immediately placed in hot 
lysis buffer (10 mM Tris, 50 mM NaCl, 100 mM EDTA, 2% N-lauryl sarcosine 
(NLS), pH 7.6 and freshly added 0.2mg/ml protease), and initially incubated at 
4°C for 30 min and then at 50°C for 18h (Paul et al., 2013). 
For the evaluation of IR induced DSB repair kinetics 16 x 106 cells were 
pre-treated for 1 h in 4 ml medium containing 100 µM Caspase Inhibitor III, 
cooled to 4°C and irradiated on ice. After irradiation, cells were quickly returned 
to 41°C for repair. After each repair time interval, cells were collected by 
centrifugation, washed with PBS and embedded in 0.5% Agarose prepared in 
fresh serum free growth medium at a final concentration of 7 x 106 cells/ml, as 
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described above. Cells in the plugs were lysed in hot lysis buffer by initially 
incubation at 4°C for 30 min and then 50°C for 18h. Subsequently, after the 
lysis step plugs were transferred to washing buffer (10 mM Tris, 100 mM EDTA, 
50 mM NaCl, pH 7.6) for 1 h at 37°C and then treated for 1 h with 0.1 mg/ml 
RNase A in washing buffer at 37°C. To determine the signals generated by 
non-irradiated cells as background, cells from identically treated non-irradiated 
cultures were processed at pre-defined times, e.g. 15 min and 4 h (Paul et al., 
2013). 
AFIGE was carried out in 0.5% agarose (Lonza) and the gels were presatined 
with 0.5 μg/ml EtBr. The run was carried out in 0.5 x TBE (45 mM Tris, pH 8.2, 
45 mM Boric Acid, 1 mM EDTA) at 8°C for 40 h using conventional gel boxes 
(Horizon 20•25) connected to a switching apparatus. During this time cycles of 
50 V (1.25 V/cm) for 900 s in the direction of DNA migration (forward) alternated 
with cycles of 200 V (5.0 V/cm) for 75 s in the reverse direction. Gels were 
scanned in the Typhoon and analyzed using the Image-Quant software (GE 
Biosciences). The fraction of DNA released (FDR) from the well into the lane is 
a measure of DSBs present and is plotted as a function of dose. FDR was 
calculated using ImageQuant 5.0 software and FDR values of non-irradiated 
samples (background) was subtracted from the FDR measured in samples 
exposed to IR. To obtain dose response curves, induction of DSBs was 
measured at different radiation doses, and FDR was plotted against radiation 
dose. In order to facilitate the inter comparison of results obtained by different 
mutants, and to account for differences in the dose response curves between 
different cell lines and experiments, repair kinetics are not presented as FDR 
versus time, but rather as dose equivalent (Deq) versus time. We used dose 
response curves to deduce Deq values from each FDR value. The obtained 
repair kinetic curves were fitted using non-linear regression analysis of 
SigmaPlot 12.0 software. In general, two components, a fast and a slow one, 
were assumed to exist in the repair curves and fitting algorithms were selected 
accordingly (Paul et al., 2013).  
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3.2.17 Immunofluorescence microscopy 
For immunofluorescence staining approximately 106 cells were spun for 3 min 
at 1,500 x g on coverslips using cytospin. Cells were washed once with PBS 
and fixed for 15 min at room temperature with 2% PFA (2% paraformaldehyde 
in PBS, pH 7.4). Alternatively, cells were collected in cold PBS to 2 x 106 
cells/ml and 50–100 µl per sample were layered on adhesion slides 
(ImmunoSelect Adhesion slides, Squarix). Adhesion slides were kept on ice and 
cells were left to attach for 15 min to the slide surface by gravity. Adhesion 
slides needed to be prepared using a liquid blocker pen (PAP pen for 
immunostaining, Sigma-Aldrich) to generate a drawn edge of a hydrophobic 
circle for every sample. Attached cells were fixed at room temperature for 
15 min by adding 2% PFA. Generally, after washing with 1 x PBS, cells were 
permeabilized for 5 min in P-solution (0.5% Triton X-100 in 100 mM Tris, 50 mM 
EDTA, pH 7.4) and were blocked in PBG solution (0.5% BSA, 0.2% Gelatin in 
PBS) overnight at 4°C or 1 h at room temperature. 
For visualization of -H2AX foci, cells slips were incubated for 90 min at room 
temperature with an anti--H2AX mouse monoclonal antibody (JBW301, 
Upstate) diluted 1:200 in PBG solution. Cells were washed three times with 1 x 
PBS and an anti-mouse IgG antibody, conjugated with AlexaFluor488 
(Invitrogen), was added for 60 min at room temperature in 1:400 dilution. Cell 
nuclei were counterstained for 30 min with DAPI (0.025 µg/ml 4′,6-Diamidin-2-
phenylindol (DAPI), 100 mM Tris pH 7.0, 100 mM NaCl, 5 mM MgCl2, 0.05% 
Tritin X-100), washed once with PBS and mounted using Prolong-Gold Antifade 
(Invitrogen). Immunofluorescence images were either captured on Leica TCS 
SP5 confocal scanning microscope using LAS AF software and were further 
processed using Imaris software (Bitplane), or samples were scanned using a 
40x objective in an automated analysis station equipped with a fluorescence 
microscope (AxioImager Z2, Zeiss) and controlled by Metafer software 
(MetaSystems). On average, 4000 cells per sample were scored and analyzed 
using the same software. Using DAPI signal intensity one was able to analyze 
cell cycle distribution and to distinguish cells separately in the cell cycle (i.e., G1 
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and early S, termed here as G1) and late in the cell cycle (i.e., late S and G2, 
termed here as G2). 
 
3.2.18 Live Cell Imaging 
To study intracellular localization of LIG3 we used DT40 cells expressing 
different GFP fusion proteins as described recently (Paul et al., 2013). Cells 
were placed in glass coverslip bottom dishes and incubated at 41°C in a 
humidified incubator. DT40 cells expressing a LIG3-GFP fusion protein were 
directly stained for mitochondria visualization with 150 nM MitoTracker 
DeepRed (Invitrogen) for 1 h and for nuclei visualization with 1 µg/ml Hoechst 
33342 (Invitrogen) for 30 min. Immunofluorescence images of live cells were 
captured on a Leica TCS SP5 laser scanning confocal microscope using the 
LAS-AF software (Leica Microsystems) and were further processed using the 
Imaris software (Bitplane). 
 
3.2.19 In vitro assay of NHEJ 
Important insights into the biochemical mechanisms of DSB repair have been 
obtained using diverse plasmid-based in vitro assays. In the majority of in vitro 
NHEJ assays developed to date, the substrate DNAs used is obtained by 
restriction enzyme cleavage of plasmid DNA, while end-joining proteins are 
derived from cell or tissue extracts. Here we use the previously well described 
plasmid-based assay for DNA end-joining in vitro (Iliakis et al., 2005), where 
whole cell extracts prepared from cells efficiently support the joining in pSP65 
plasmid of SalI-produced DSB ends with 4 nucleotide 5’-cohesive overhangs to 
generate circles, dimers and multimers by LIG3 (Cotner-Gohara et al., 2010; 
Wang et al., 2005). 
In vitro end-joining was measured with the pSP65 plasmid (3 kb, Promega) after 
linearization with SalI. End-joining reactions were performed in NHEJ buffer 
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(20 mM HEPES-KOH pH 7.5, 10 mM MgCl2, 80 mM KCl, 1 mM ATP, 1 mM 
DTT) with 50 ng of substrate DNA (pSP65-SalI) and 0.5–2 µg of whole cell 
extract in a final volume of 20 µl at 25°C for 1 h. Reactions were terminated by 
adding 5 µl of stop solution (2 µl 5% SDS, 2 µl 0.5 M EDTA and 1 µl protease 
(10 mg/ml) and incubating for 30 min at 37°C. To the reaction 5 µl of 6 x DNA 
loading buffer (30% glycerol, 50 mM EDTA pH 8.0, 100 mM Tris-HCl pH 8.0, 
0.01% bromophenol blue) was added and half of the reaction was loaded on a 
0.7% agarose gel and run at 45 V (2 V/cm) for 4.5 h. Gels were stained with 
1:10.000 SYBR Gold (Molecular Probes) and scanned in a FluorImager 
(Typhoon, Molecular Dynamics). For quantification of rejoining the ImageQuant 
software (Molecular Dynamics) was used to calculate the percent of input 
plasmid found in circles, dimers and other higher order multimers. 
 
3.2.20 Plasmid Preparation 
The supercoiled plasmid pSP65 (3 kb; Promega) utilized in the in vitro assay of 
NHEJ was prepared using CsCl/EtBr gradients (Iliakis et al., 2005) or using a 
NucleoBond Xtra Midi/Maxi Plus EF purification kit (Macherey-Nagel) following 
the instruction manual (Paul et al., 2013). For CsCl/EtBr gradients, a 1 liter 
culture of plasmid-transformed E.coli was grown in Lysogeny Broth medium 
(LB, 10 g/l tryptone, 5 g/l yeast extract, 10 g/l NaCl) containing Ampicillin (Amp, 
100 mg/ml in H2O) in a final concentration of 100 µg/ml to an OD600 of 1.0 and 
then chloramphenicol (Cm, 34 mg/ml in ethanol) to a final concentration of 
150 μg/ml was added. Cells were grown overnight and were collected by 
centrifugation for 30 minutes at 1,300 x g and 4°C. The pellet was resuspended 
in 10 ml Sucrose/Tris/EDTA solution (25% sucrose, 50 mM Tris-HCl pH 8.0, 
40 mM EDTA pH 8.0) and 2 ml of freshly prepared lysozyme (10 mg/ml in 
Sucrose/Tris/EDTA solution) was added and gently mixed. Cells were incubated 
for 30 minutes at room temperature and then 4 ml Triton lysis mix (2% Triton 
X-100, 50 mM Tris-HCl pH 8.0, 40 mM EDTA pH 8.0) was added and mixture 
was incubated at least 30 min at 37°C with occasional swirling. Subsequently, 
lysates were centrifuged for 1 hour at 25.000 rpm (48.400 g) in a Beckman 
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JA25.50 rotor. Supernatant was removed and volume determined to add 0.95 g 
cesium chloride per ml while making sure that it was completely dissolved. Then 
0.1 ml/ml supernatant of EtBr solution (10 mg/ml) was added to the 
supernatant. Mixture was centrifuged for 20 min in a Beckman JA 25.50 rotor at 
7.000 rpm to remove protein and debris. Then it was transferred to an 
ultracentrifuge tube (Beckman, 4.2 ml, 6.3 ml or 8 ml) and centrifuged for 16 h 
at 20°C in an ultracentrifuge (Beckman:Optima Max) in a near vertical rotor 
MLN80 at 70.000 rpm (240.000 x g). Subsequently, the lower band, containing 
the supercoiled plasmid, was removed and was transferred to a new 4.2 ml 
ultracentrifuge tube. CsCl/TE solution containing 0.2 mg/ml EtBr was added to 
fill the tube which was centrifuged again as described above. The lower band 
was removed and extracted with 1:1 phenol/chloroform twice and precipitated 
with ethanol overnight at –20°C. Pellet was extracted once more with 
phenol/chloroform and precipitated with ethanol. The resulting pellet was 
dissolved in 1 x Tris-EDTA buffer (TE, 50 mM Tris-HCl pH 8.0, 40 mM EDTA 
pH 8.0). After dialysis against 1 x TE overnight concentration of plasmid was 
determined with a spectrophotometer (NanoDrop; Thermo Scientific). 
 
3.2.21 Plasmid Digestion 
pSP65 was used as a substrate in DNA end-joining reactions after digestion 
with SalI (Promega/Fermentas) to generate linearized DNA as previously 
described (Iliakis et al., 2005; Paul et al., 2013). Gel electrophoresis was used 
to test the completeness of digestion. The completely digested plasmid was 
again purified with phenol/chloroform extraction, precipitated with isopropanol 
and the precipitate was washed twice with 70% ethanol. The air-dried plasmid 
pSP65-SalI was dissolved in 1 x TE buffer aiming a concentration of 50 ng/ml. 
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3.2.22 Extract preparation 
The above described in vitro end-joining experiments (see 3.2.19) were 
performed using whole cell extracts (WCE) (Iliakis et al., 2005; Paul et al., 
2013). For the preparation cells were collected, washed once with ice-cold 1 x 
PBS and subsequently with 5 ml of cold hypotonic buffer (10 mM Hepes-KOH 
pH 7.5, 5 mM KCl, 1.5 mM MgCl2, 0.2 mM phenylmethylsulfonyl fluoride 
(PMSF) and 0.5 mM 1,4 Dithiothreitol (DTT)) and centrifuged. The cell pellet 
was resuspended in three packed volumes of hypotonic buffer and, after 10 min 
on ice, subjected to three freeze–thaw cycles with liquid nitrogen and a 37°C 
water bath by keeping carefully ice temperature. Afterwards, 1/5 volume of 3 M 
KCl was slowly added to the lysate to reach a final concentration of 500 mM 
KCl. After 30 min incubation at 4°C on a rotation platform, the sample was 
cleared by centrifugation for 40 min at 14,000 rpm at 4°C. The supernatant was 
removed as WCE and dialyzed overnight against dialysis buffer (25 mM Hepes, 
pH 7.5, 10% Glycerol, 400 mM KCl, 1 mM EDTA, 0.2 mM PMSF and 0.5 mM 
DTT). Dialyzed extracts were cleared by a second centrifugation for 40 min at 
14,000 rpm at 4°C and aliquots of the extract were snap frozen and stored at –
80°C. 
 
3.2.23 SDS-PAGE and Western blotting 
Protein gel electrophoresis under denaturating conditions was carried out using 
WCE prepared as described above (see 3.2.22). Protein concentration of WCE 
was determined by colorimetric Bradford assay. WCE were mixed with 2 x 
Laemmli sample buffer (65 mM Tris-HCl pH 6.8, 10 mM EDTA, 20% glycerol, 
3% Sodium dodecyl sulfate (SDS), 0.02% bromophenol blue, 50 µl/ml β-ME), 
denaturated at 95°C for 5 min and spun down for 1 min at 13,000 x g before 
electrophoresis. Protein separation was performed by electrophoresis on SDS-
polyacrylamide mini gels (“Mini PROTEAN”, Bio-Rad), consisting of a 5% 
stacking gel and a 10% resolving gel. WCE were loaded with a total protein 
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amount of 20 μg on SDS polyacrylamide gels and resolved at a constant 
voltage of 130 V for 1.5 h at RT (Paul et al., 2013). 
For Western blot analysis, proteins were transferred onto 0.2 µm Nitrocellulose 
or polyvinylidene difluoride (PVDF) membranes using an iBlot dry transfer 
system (Invitrogen. The self-contained iBlot device uses disposable blotting 
stacks with integrated nitrocellulose or PVDF membranes that efficiently and 
reliably blots proteins from polyacrylamide gels on membranes in less than 10 
min without the need for additional buffers or an external power supply. Equal 
loading and transfer efficiency were monitored by immunodetection of GAPDH. 
After transfer, membranes were incubated in blocking buffer (5% non-fat dry 
milk in 0.1% Tween-20, 150 mM NaCl, 25 mM Tris-HCl, pH 7.6) for 1-2 h at 
room temperature. Subsequently, membranes were incubated overnight at 4˚C 
with primary antibody appropriately diluted in blocking buffer. After three 
washes for 10 min with TBS-T (0.1% Tween-20, 150 mM NaCl, 25 mM Tris-
HCl, pH 7.6), membranes were incubated for 1 h with secondary antibody 
appropriately diluted in blocking buffer. Membranes were scanned using the 
Odyssey infrared imaging system (Li-COR) or were developed for 
chemiluminescence detection by using ECL+ chemiluminescence detection kit 
(GE Healthcare) as recommended by the manufacturer. Signals were visualized 
in a VersaDoc imaging system (Bio-Rad) and analyzed with the Quantity one 
software (Bio-Rad). The following primary antibodies were used: anti-LIG3 
(1F3) mouse mAb (GeneTex); anti-LIG1 (10H5) mouse mAb (Santa Cruz), anti-
α-Tubulin (AA13) mouse monoclonal (Sigma Aldrich), anti-histone H1 (AE-4) 
mouse mAb (Acris), and anti-GAPDH mouse mAb (Millipore). The secondary 
antibody was an anti-mouse IgG conjugated with HRP (Cell Signaling), 






Early work from our laboratory, as well from the laboratories of other 
investigators, provides strong biochemical evidence for the putative involvement 
of LIG3 in B-NHEJ. Recent studies from our lab showed an impressive 
functional redundancy between LIG3 and LIG1 in DNA replication (Arakawa et 
al., 2012). For a conclusive elucidation of the function of LIG1 and LIG3 in DSB 
repair, we generated a set of conditional knockout, knockout and knock-in 
mutants in chicken DT40 cells. This set of mutants (summarized in Table 5) 
includes, in addition to single knockouts for all three DNA ligases, also double 
ligase knockout mutants, as well as ligase knock-in mutants in appropriately 
selected, DNA ligase genetic background to study the interplay between DNA 
ligases in DSB repair. 
 
4.1 LIG1 and LIG4 are not essential for survival of 
higher eukaryotic cells 
As a first step in the characterization of the generated mutants we investigated 
the consequences of DNA LIG1 and LIG4 depletion in cell growth (Arakawa et 
al., 2012). For these experiments, the cells were maintained in the logarithmic 
phase of growth by daily subculturing with fresh growth medium to keep cell 
density between 1 to 2 x 106 cells/ml. The cell cycle distribution of the wild type 
and mutant cell lines was also measured every day by FACS analysis. The 
obtained DNA histograms and growth curves for wild type (wt), single LIG1-/- or 
LIG4-/ mutants and for double LIG1-/-LIG4-/- mutant cells are summarized in 
Figure 18. 
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According to these results, wild type cells grow with similar growth kinetics and 
show no change in cell cycle distribution in the presence or absence of 4HT, 
indicating no drug side effects. Nevertheless, in the conditional LIG3 
background, deletion of LIG3 by 4HT treatment has severe consequences for 
the cells. Cell growth ceases completely after 4 days and LIG3-/2loxP and 
LIG3-/2loxPLIG4-/- cells start dying (Figure 19A and 19B) (Arakawa et al., 2012). 
In addition, the flow cytometry results of 4HT treated LIG3-/2loxP and 
LIG3-/2loxPLIG4-/- cells indicate an extensive activation of apoptosis displayed by 
the increased population of sub-G1 cells and an unusual accumulation of cells 
in S-phase (Figure 19 upper panel). 
 
For a validation of the results of the conditional knockout system and a more 
specific determination of LIG3 activity in LIG3-/2loxP and LIG3-/2loxPLIG4-/- cells 
exposed to 4HT, we followed the induction of the conditional LIG3 knockout 
measuring LIG3 mRNA levels using RT-PCR and survival using the colony 
formation assay (Arakawa et al., 2012; Paul et al., 2013). The results obtained 
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Figure 20: LIG3 is essential for survival (Arakawa et al., 2012). (A) LIG3 mRNA levels 
related to levels of untreated cells measured by RT-PCR. (B) Colony forming ability of the 
indicated mutants treated with 4HT in comparison to their untreated counterparts and wt 
cells as a control. 
 
Treatment of the cells with 4HT initiates translocation of Cre into the nucleus 
and excision of the conditional LIG3 allele. This event results in a rapid 
reduction of LIG3 mRNA quantity to undetectable levels 12 h after 4HT 
induction (Figure 20A) (Arakawa et al., 2012; Paul et al., 2013). Notably, cell 
viability as measured by colony formation remains unchanged for the duration 




with LIG3-/2loxP and LIG3-/2loxPLIG4-/- cells grown in the absence of 4HT, although 
in this case growth is somewhat compromised and survival obviously lower. 
This suggests effects of LIG3 haploinsufficiency in conditional LIG3 mutants. 
However, colony forming ability in 4HT treated conditional knockout cells drops 
to zero at the first time point within 24h, while the survival of the untreated 
control cells, as well as the 4HT treated wt cells, remains unchanged, which 
may reflect a disconnect between mRNA levels and the stability of the LIG3 
protein (Figure 20B) (Arakawa et al., 2012). 
In addition, we quantitatively evaluated LIG3 activity in an in vitro end-joining 
assay as a function of time after addition of 4HT to LIG3-/2loxP and 
LIG3-/2loxPLIG4-/- cells (Paul et al., 2013). Due to the assumption that a functional 
decrease in ligation activity will become apparent after the protein is degraded, 
the time frame for this experiments was protracted to 120 h after induction with 
4HT. Therefore, we prepared whole cells extracts from 4HT treated cells and 
utilized them in a plasmid-based in vitro assay, detecting mainly LIG3 activity. 
The ligation substrate in this assay was pSP65 plasmid DNA, harboring a single 
SalI restriction endonuclease site. Incubation with SalI results in linearization of 
the plasmid and the generation of two cohesive 5’ overhang DNA ends. The 
ligation activity of the WCE used in the DNA end-joining reactions generates 
circles, dimers and multimers (Figure 21). It was initially difficult to monitor LIG3 
protein levels by Western blotting, due to the absence of a commercially 
available antibody raised against the chicken LIG3 protein. This obstacle was 
eliminated later by optimization of the Western blot procedure with available 
antibodies raised against hLIG3 peptide (results not shown).  
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treatment. A similar initial activity and then reduction in end-joining is also 
observed in extracts of 4HT treated LIG3-/2loxPLIG4-/- cells (Figure 21B), in line 
with earlier reports that LIG3 mainly catalyzes end-joining under the conditions 
employed (Wang et al., 2005). Thus, LIG3 activity measurements using this 
in vitro end-joining assay provide relevant information on the function of the 
conditional knockout (Paul et al., 2013). 
Taken together, the observations show a fast, efficient and complete, Cre 
nuclease mediated, 4HT induced excision of the second LIG3 allele and an 
induction of the complete LIG3 knockout. Subsequently LIG3 activity is reduced 
with an associated appearance of cell death. In agreement with earlier reported 
mouse data (Puebla-Osorio et al., 2006), we conclude that LIG3 is essential for 
survival of higher eukaryotic cells (Paul et al., 2013). 
Based on the above results we decided to utilize conditional LIG3 knockout 
mutants in the following repair experiments always after 3 to 3.5 days of 4HT 
treatment, as at this point LIG3 activity is largely reduced but the cells are still 
viable to perform experiments (Paul et al., 2013). 
 
4.3 LIG3 knockout lethality is due to a 
mitochondrial defect 
The unique property of the LIG3 gene of higher eukaryotes to express a 
mitochondria-specific form raises the possibility that this protein is essential for 
the maintenance and function of this particular cellular organelle. The lethality 
observed in the experiments described above could therefore be attributed to 
specific functions of LIG3 in the mitochondria, which cannot be complemented 
by any of the other ligases expressed in DT40 cells. To address this question, 
we tested mitochondria integrity and function in 4HT treated LIG3-/2loxP and 





Firstly, we measured the relative oxygen consumption in a sample using an 
enclosed oxygen electrode. The results are displayed in Figure 22. 
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Figure 22: LIG3 knockout lethality is due to a mitochondrial defect. Relative oxygen 
concentration of 4HT treated wt (A) and LIG3-/2loxP (B) cells. Oxygen consumption was 
measured in a sample using an oxygen electrode attached to a Licox CMP Oxygen 





A drop in partial pressure is a direct measure of oxygen consumption by the 
cells. Wild type cells cause a rapid reduction in dissolved oxygen that remains 
unaffected by the presence of 4HT. LIG3-/2loxP cells show oxygen consumption 
similar to that of wt cells in the absence of 4HT. But a gradual reduction in 
oxygen consumption is noted at day three after 4HT treatment – the time point 
when cells start to die. 
Secondly, for a direct measurement of the cellular ATP load in wt and LIG3-/2loxP 
cells at different times after treatment with 4HT we employed a 
luciferin/luciferase based assay and the acquired results are summarized in 
Figure 23. 
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Figure 23: LIG3 knockout lethality is due to a mitochondrial defect. Cellular ATP load in 
wt and LIG3-/2loxP cells after treatment with 4HT evaluated with CellTiter-Glo Luminescent 
Cell Viability Assay, a luciferin/luciferase based assay which generates a luminescent 
signal proportional to the amount of ATP present. Each determination was carried out 
using 2 x 104 cells and results shown are referred to ATP levels of untreated wt cells. 
 
Notably, the method used for ATP determination is very sensitive; for example 
the produced luminescent signal from 50 cells is greater than three times the 
background signal from serum supplemented medium without cells. The slight 
changes in ATP levels of 4HT treated wt cells could be ascribed to dilution 
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Here again, LIG3-/2loxP cells show compared to the wt only slight differences in 
MitoTracker signal. But in the presence of 4HT the MitoTracker signal drops 
gradually as cells begin to die after 4 days of 4HT treatment. The results 
suggest reduction in mitochondria membrane potential in line with oxygen 
consumption and the ATP load results described above. 
As a final parameter we defined the nuclear fragmentation, as a criterion to 
evaluate cell death by apoptosis after 4HT treatment. This parameter is 
expressed as apoptotic index (AI) and represents the number of cells with 
fragmented nuclei as percentage of the total number of cells in the population. 
The results obtained are summarized in Figure 25. 
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Figure 25: LIG3 knockout leads to apoptosis. Apoptotic index determined by counting 
the fraction of cells showing nuclear fragmentation among 1000 cells in the population. 
 
Compared to wt cells the AI of LIG3-/2loxP cells is only slightly higher in the 
absence of 4HT. After 4HT treatment the AI of LIG3-/2loxP cells increases rapidly 
from 30% at day four to 80% at day five. Notably, the increase of the AI after 
four days of 4HT treatment indicates a coincidence between viability loss, on 
the one hand, and a reduction mitochondria function, on the other hand. 
The above outlined results show a timely parallel induction of apoptosis and a 
deterioration of mitochondria function in LIG3 depleted cells, that makes it 




primary chicken embryo fibroblasts can survive after depletion of their 
mitochondria (Desjardins et al., 1985), it is possible that what we observe here 
are LIG3 mediated mitochondria effects that specifically affect apoptosis 
signaling in the highly pro-apoptotic DT40 cells. According to this interpretation, 
LIG3 depletion induces lethality in DT40 by interfering with the mitochondrial 
regulation of apoptosis. 
 
4.4 Knock out of LIG3 has no detectable effect on 
DSB repair in LIG4 and LIG1 proficient cells 
While LIG4 is solidly implicated in D-NHEJ pathway of DSB repair, the ligase 
responsible for B-NHEJ is less well characterized. Early work from our 
laboratory, as well from the laboratories of other investigators, provides strong 
biochemical evidence for the involvement of LIG3 in B-NHEJ (Wang et al., 
2005). 
As a result of single allele expression, LIG3 mRNA is in LIG3-/2loxP cells 50% 
reduced (Figure 26A). To examine the effect on DSB processing of a further 
reduction in LIG3 protein level, we analyzed IR induced DSB repair kinetics 
using PFGE (Paul et al., 2013). Figure 26B shows the results obtained with 
LIG3-/2loxP cells as compared to wt cells after treatment with 4HT for 3 or 































LIG3-/2loxP + 4HT 3 d 
LIG3-/2loxP + 4HT 3.5 d 
Figure 26: Knockout of LIG3 has not detectable effect on DSB repair (Paul et al., 2013). 
(A) LIG3 mRNA levels in wt and LIG3-/2loxP cells measured by RT-PCR. (B) Repair kinetics 
of IR-induced DSBs in asynchronous wt and LIG3-/2loxP cells after treatment with 4HT for 
the indicated periods of time. Results of three determinations from at least two 
independent experiments were used to calculate the indicated means and standard 
errors. 
 
Wt DT40 cells efficiently repair DSBs induced by high doses of IR with half 
times of less than 30 min. Ninety percent of DSBs induced by 40 Gy X-rays are 
processed in these cells within 1 h, and their number is below the detection limit 
of PFGE 4 h later. Moreover, LIG3-/2loxP cells process DSBs with kinetics 
indistinguishable from that of wt cells. Since the heterozygous nature of the 
LIG3-/2loxP mutant causes a 50% reduction in LIG3 mRNA and consequently 
presumably also in LIG3 protein level, we conclude that reductions of this 
magnitude leave unchanged the ability of the cells to deal with DSBs (Paul et 
al., 2013). 
To examine whether lower levels of LIG3 compromise DSB repair we treated 
LIG3-/2loxP cells with 4HT and analyzed DSB repair efficiency at different times 
thereafter (Figure 26B). Since cells die after five days as a result of apoptosis 
(see above 4.3), we carried out experiments within this time frame to avoid 
complication in the interpretation of the results. The results summarized in 
Figure 26B indicate that more than 90% reduction in protein activity 




conclude that under these conditions other DNA ligases, and predominantly 
LIG4, carry out repair of DSBs. These results confirm that LIG3 is unlikely to 
have a primary role in DSB repair and that its task most probably is limited to 
back up the functions of LIG4 (Paul et al., 2013). 
 
4.5 A contribution of LIG3 in DSB repair is clearly 
detectable in a LIG4-/- genetic background 
To study the putative role of LIG3 in B-NHEJ we knocked out LIG4, using 
standard approaches in a wt and LIG3-/2loxP genetic background and studied 
repair of DSBs by PFGE in the presence or absence of 4HT (Paul et al., 2013). 
The results for LIG3-/2loxPLIG4-/- double mutant cells are shown in Figure 27. 
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Figure 27: A contribution of LIG3 in DSB repair is clearly detectable in a LIG4-/- genetic 
background (Paul et al., 2013). Repair kinetics of IR-induced DSBs in asynchronous wt, 
LIG4-/- and LIG3-/2loxPLIG4-/- cells after treatment with 4HT for the indicated periods of time. 
Results of three determinations from at least two independent experiments were used to 






As expected, LIG4-/- cells show, compared to the wt and LIG3-/2loxP cells a 
pronounced defect in DSB repair by the resulting inhibition of D-NHEJ. Despite 
this repair defect, a robust alternative repair pathway removes ~50% of the 
generated DSBs within 1h and nearly 80% in 4h. This alternative form of NHEJ 
must utilize LIG1 or LIG3, the only remaining ligases in this mutant. The repair 
efficiency in the LIG3-/2loxPLIG4-/- double mutant is similar to that of LIG4-/- 
mutant suggesting that even in this background reduction by 50% of the cellular 
LIG3 level has no effect on DSB repair capacity. Further reduction of LIG3 by 
treatment with 4HT for 3.5 days compromises DSB repair. Since the level of 
LIG3 at the latest time point measured may not be zero, residual DSB repair 
activity may be attributed to residual LIG3 or to LIG1. This result further 
demonstrates the contribution of LIG3 to B-NHEJ and confirms earlier 
observations that even low levels of LIG3 are sufficient to support efficient 
B-NHEJ (Paul et al., 2013; Windhofer et al., 2007a).  
 
4.6 A double mutant conclusively shows the 
function of LIG3 in B-NHEJ 
For a conclusive elucidation of the function of LIG1 and LIG3 to DSB repair, we 
generated a set of knockout and knock-in mutants in chicken DT40 cells. This 
set of mutants (summarized in Table 5) contains, in addition to single knockouts 
for all three DNA ligases, also double knockout mutants. To study the role of 
LIG1 in DSB repair we knocked out this ligase in wt and LIG4-/- genetic 






















Figure 28: LIG3 repairs DSBs in a LIG1 and LIG4 deficient background (Paul et al., 2013). 
Kinetics of DSB processing in asynchronous wt, LIG1-/-, LIG4-/-, and LIG1-/-LIG4-/- cells 
after exposure to 40 Gy X-rays. Results of three determinations from two independent 
experiments were used to calculate the indicated means and standard errors. 
 
The results presented in Figure 28 demonstrate that LIG1-/- cells repair the 
generated DSBs with kinetics indistinguishable from those of wt cells. Thus, a 
contribution of LIG1 to DSB repair is undetectable in the presence of the two 
other DNA ligases (Paul et al., 2013). 
Similarly, LIG1-/-LIG4-/- double knockout cells repair DSBs with kinetics identical 
to those of LIG4-/- cells, showing that a deletion of LIG1 in a LIG4-/- background 
generates no additional DSB repair defect beyond these observed in LIG4 
deficient cells. Thus, the robust processing of DSBs in the LIG1-/-LIG4-/- double 






4.7 -H2AX foci formation and decay confirms the 
results of PFGE 
PFGE is a reliable method for determination of the induction of DSBs and their 
physical rejoining, but experiments are carried out at relatively high radiation 
doses to accommodate the sensitivity of PFGE as method, which might 
consequences for the results obtained. There are hints that DSB repair pathway 
selection could be affected by the load of DNA damage registered in the cell 
and therefore is also relevant to design experiments using lower doses of 
radiation. We therefore wished to confirm the main conclusions from the PFGE 
experiments with experiments at low doses. Therefore, we measured -H2AX 
foci formation and decay after irradiation with 0.5 and 1 Gy X-rays (Paul et al., 
2013). The kinetics of -H2AX foci formation that reflects DSB related signaling 
and those of the removal of physical breaks measured by PFGE are widely 
different and have been discussed. Nevertheless, -H2AX foci scoring 
represents an acceptable surrogate for physical DSB determination (Kinner et 
al., 2008). -H2AX are frequently used as markers for DSBs and it has been 
reported that the number of -H2AX foci correlates with the number of DSBs 
present, and that it increases linearly with radiation dose (Rothkamm and 
Löbrich, 2003). 
The -H2AX foci results obtained for wt, LIG1-/-, LIG4-/-, and LIG1-/-LIG4-/- cells 
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As expected, the rate of DSB induction in DT40 cells does not significantly differ 
between wt and mutant cell lines and is about 9-12 foci per cell, which is two 
times lower than the -H2AX foci yields measured in mouse or human cells. 
This number correlates with the smaller genome size of DT40 cells; likewise 
they exhibit a two times lower DNA content. Moreover, DT40 wt cells efficiently 
repair DSBs at the applied radiation doses, as indicated by the disappearance 
of -H2AX foci after an initial peak reached ~1 h after IR exposure (Figure 29A). 
The kinetics of -H2AX foci formation and decay in LIG1-/- cells (Figure 29B) are 
identical to those of wt cells, confirming the corresponding results with PFGE. 
The efficiency of -H2AX foci decay is reduced in LIG4-/- cells (Figure 29C) in 
line with the expected defect in D-NHEJ. The function of LIG3 in this set-up is 
confirmed by the results obtained with the double mutant LIG1-/-LIG4-/- (Figure 
29D) (Paul et al., 2013). In general, the same pattern of -H2AX foci formation 
and decay, with the initial peak arising 1 h after IR and with a subsequent decay 
is found in all four investigated mutants. 
For a better comparison, we also plotted the remaining -H2AX foci scored 8 h 





































Figure 30: LIG3 supports processing of DSBs also after low doses of radiation (Paul et 
al., 2013). -H2AX foci scored in wt, LIG1-/-, LIG4-/-, and LIG1-/-LIG4-/- cells 8 h after 




subtracted. Results of two independent experiments, in which 8000 nuclei on average 
were scored, were used to calculate the indicated means and standard errors. 
The number of residual -H2AX foci 8 h after exposure to 1 Gy is in LIG1-/- cells 
is similar to the wt, suggesting, in agreement with previous PFGE experiments, 
similar repair capacity. Higher numbers of residual -H2AX foci are detected, as 
expected, in LIG4-/- cells, but this repair defect is not further enhanced in the 
double mutant LIG1-/-LIG4-/- (Paul et al., 2013). 
The above observations in aggregate suggest that independently of the applied 
radiation dose, LIG3, as sole ligase, supports processing of DSBs in D-NHEJ 
deficient cells and that LIG1 is not required for this function. We further 
conclude that the DSB repair pathways within which LIG3 operates, process 
DSBs with kinetics slower than D-NHEJ (Paul et al., 2013). 
 
4.8 A mitochondria specific LIG3 rescues DT40 
cells lethality but has no influence on DSB 
repair 
The lethality of LIG3 knockout limits the conclusive analysis of LIG3 and LIG1 
function and their interplay during DSB repair. However, in agreement with 
recent studies, we observed that DT40 cell lethality associated with LIG3 
knockout can be rescued by expressing a mitochondria specific form (M2I). The 
generated LIG3-/M2I, mutant carries one null LIG3 allele and one altered allele 
that lacks the second translation initiation site (M2I), which is needed to 
generate the nuclear version of LIG3 (Arakawa et al., 2012). This mutant 
expresses exclusively the mitochondrial form of LIG3 which can be visualized 
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Figure 32: A mitochondria specific LIG3 rescues DT40 cells lethality but has no influence 
on DSB repair (Paul et al., 2013). Kinetics of DSB repair in wt, LIG3-/2loxP, LIG3-/M2I, LIG4-/- 
and LIG3-/M2ILIG4-/- after exposure to 40 Gy X-rays. Results from at least two independent 
experiments with 4 samples each were used to calculate the indicated means and 
standard errors. 
 
The resulting mutant LIG3-/M2I grows normally (data not shown) and shows 
normal levels of DSB repair similar to those of wt and LIG3-/2loxP cells. Under 
these conditions, DSB repair is supported by LIG4, LIG1 and, possibly, traces of 
LIG3 that remain in the cell nucleus. 
The double mutant LIG3-/M2ILIG4-/- shows a slightly reduced potential for DSB 
repair when compared to the single LIG4-/- mutant. 
These results implicate LIG1 in B-NHEJ taking place in the absence of LIG4 
and suggest that the efficiency of LIG1 for this function is lower than that of 
LIG3. In fact, it is possible that DSB rejoining in this mutant would be further 







4.9 Deletion of LIG3 reveals a function of LIG1 in 
the processing of IR-induced DSBs by B-NHEJ 
In an effort to generate a better defined system to measure the role of LIG1 in 
DSB repair we designed and develop a genetic system allowing the complete 
elimination of LIG3 in DT40 cells. For this purpose, we attempted rescuing the 
mitochondria function of LIG3, which was found to be essential for cell survival, 
with the gene Cdc9. Cdc9 is the yeast homolog of LIG1 but functions also in the 
mitochondria owing to its MT signal. Indeed, Cdc9 rescues the mitochondria 
defect and allows us to generate cells entirely lacking LIG3. Since we were not 
successful in generating the LIG3-/-LIG4-/-Cdc9 double mutant, we utilized a 
specific DNA-PKcs inhibitor, NU7441, which chemically compromises D-NHEJ 
to simulate the LIG4 defect (Paul et al., 2013). The obtained DSB repair kinetics 
of LIG3-/-Cdc9 cells are displayed in Figure 33. 
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Figure 33: Deletion of LIG3 reveals a function of LIG1 in the processing of IR-induced 
DSBs by B-NHEJ (Paul et al., 2013). Kinetics of DSB repair in wt and LIG3-/-Cdc9 cells 
measured in the presence or absence of 10 µM NU7441, a DNA-PKcs specific inhibitor. 
This LIG3-/- mutant is viable as a result of the expression of the yeast homolog of LIG1, 
Cdc9 (Arakawa et al., 2012). Results from at least two independent experiments with 4 






The repair of IR induced DSBs in LIG3-/-Cdc9 is identical to wt, owing to the 
presence of LIG4 in this mutant. As was mentioned above, to study the function 
of LIG1 alone in this system we used NU7441 to inhibit DNA-PKcs and 
consequentially also D-NHEJ. The results obtained showed a stronger 
reduction in DSB repair in LIG3-/-Cdc9 cells treated with NU7441 than in 
NU7441 treated wt cells (Figure 33). 
These results confirm that in wt cells, B-NHEJ in the presence of NU7441 is 
carried out by LIG3 and provide additional evidence that LIG1, in Lig3-/-Cdc9 
cells treated with NU7441, could be involved in B-NHEJ as well. Thus, we 
conclude that LIG1 could also support B-NHEJ, albeit with lower efficiency than 
LIG3 (Paul et al., 2013). 
 
4.10 LIG1 is capable to support B-NHEJ in the 
absence of LIG3 
The structural similarity between LIG1 and LIG3 (Pascal et al. 2004) offers a 
rationale for the possible functional overlap in the functions between the two 
enzymes. To further delineate the function of LIG1 in DSB repair by B-NHEJ we 
wished to generate mutants only expressing LIG1 to avoid possible 
interferences from any other ligase. For this purpose, we generated mutants 
expressing human LIG1 with a mitochondrial leader sequence, mts-hLIG1, in a 
LIG3-/2loxPLIG4-/- background (Paul et al., 2013). In this way we were able to 
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Figure 34: Characterization of LIG3-/2loxPLIG4-/- cell clones ectopically expressing mts-
hLig1 (Paul et al., 2013). (A) Human LIG1 mRNA level measured by real-time PCR in 
clones 1-7 of LIG3-/2loxPLIG4-/-mts-hLIG1 cells normalized to that measured in clone 3. 
Results of independent determinations with two primer pairs were used to calculate the 
indicated means and standard errors. (B) Western blot analysis of hLIG1 protein level in 
clones 1-7 of LIG3-/2loxPLIG4-/-mts-hLIG1, LIG3-/2loxPLIG4-/- and Hela extracts. A mouse 
monoclonal antibody recognizing human but not chicken LIG1 was used. GAPDH is used 
as loading control. (kindly provided by E. Mladenov) (C) LIG3 mRNA level measured by 
real-time PCR in clones 1-7 of LIG3-/2loxPLIG4-/-mts-hLIG1 and parental LIG3-/2loxPLIG4-/- 
cells normalized to the levels measured in wt cells. (D) Growth kinetics of LIG3-/2loxPLIG4-/- 
cells and clones 1-7 expressing the mitochondrial version of hLig1, 
LIG3-/2loxPLIG4-/-mts-hLIG1. Cells were maintained in the exponential phase of growth by 





In all seven clones, real time PCR, using primer pairs for hLIG1, shows 
comparable mRNA levels (Figure 34A); whereas western blotting analysis 
documents some variation in protein expression (Figure 34B). Since the used 
Anti-LIG1 Ab is not able to detect the endogenous chicken LIG1, we were able 
to selectively detect the overexpressed hLIG1. All seven clones show different 
but detectable LIG1 levels in comparison to the non-transfected control. hLIG1 
apparently assists DNA replication in DT40 cells, as indicated by the improved 
growth characteristics of these clones, compared to the parental cell line 
LIG3-/2loxPLIG4-/- (Paul et al., 2013). 
In these clones one LIG3 allele is completely eliminated, while the second allele 
is conditional. All of the examined clones show the expected reduction of LIG3 
mRNA, by 50%, as compared to the wt (Figure 34C) (Paul et al., 2013). 
All seven LIG3-/2loxPLIG4-/-mts-hLIG1 mutants show a marked increase in their 
growth characteristic, which is comparable to wt cells, again highlighting the 
function of overexpressed LIG1 in replication (Figure 34D) (Paul et al., 2013). 
 
A further treatment of these clones with 4HT leads to the excision of the two 
loxP sites on the second allele and to the generation of LIG3-/-LIG4-/- cells 
rescued by mitochondrial hLIG1. These mutants express only the endogenous 
chicken LIG1 and the overexpressed mitochondrial human LIG1 (Paul et al., 
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The obtained mutants show no difference in growth characteristics in 
comparison to their untreated counterparts (Figure 35A), despite excision of the 
genomic LIG3 segment between the loxP sites and a marked reduction in 
protein level (data not shown) and undetectable LIG3 mRNA levels 
(Figure 35B). In line with this observation, they demonstrate an undetectable in 
vitro end-joining capability as well (Figure 35C) (Paul et al., 2013). For reasons 
of simplification and since all seven clones show similar characteristics, in the 
next experiments we will focus only on clones 1, 3 and 7.  
To elucidate the role of LIG1 in DSB repair in the generated mutants we 





































Figure 36: LIG1 is capable to support B-NHEJ in the absence of LIG3 (Paul et al., 2013). 
A) Kinetics of DSB repair in asynchronous LIG3-/2loxPLIG4-/- and clones 1, 3 and 7 of 
LIG3-/2loxPLIG4-/mts-hLig1 cells. B) Kinetics of DSB repair in asynchronous 
LIG3-/2loxPLIG4-/-, clones 1, 3 and 7 of LIG3-/-Lig4-/-mts-hLig1 cells and their counterparts 
after 3.5 days 4HT treatment, respectively. Results of at least three determinations from 






Analysis of DSB processing in clones 1, 3 and 4 shows that LIG3-/2loxPLIG4-/-
mts-hLIG1 does not modulate DSB repair in any way in comparison to their 
parental cell line LIG3-/2loxPLIG4-/-. The same clones analyzed five days after 
treatment with 4HT to generate LIG3-/-LIG4-/-mts-hLIG1 mutants show DSB 
processing with no difference in comparison to the untreated ones and better 
repair than the control cell line LIG3-/2loxPLIG4-/- 3.5 days after treatment with 
4HT (Paul et al., 2013). 
We conclude that the endogenous chicken LIG1 in the nucleus can support B-
NHEJ with efficiencies similar to that of LIG3. Of course, we cannot exclude that 
traces of the overexpressed mts-hLIG1 reach the cell nucleus and also support 
to B-NHEJ (Paul et al., 2013). 
 
4.11 LIG3 and LIG1 support cell survival in D-NHEJ 
deficient cells exposed to IR albeit with lower 
efficiency than LIG4 
As a final endpoint for DSB repair, radiosensitivity to killing was determined in 
the generated mutants using the colony formation assay (Paul et al., 2013). The 
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Figure 37: LIG1 and LIG3 contribute to the survival of cells exposed to IR (Paul et al., 
2013). A) Cell survival measured by colony formation in wt, Lig1-/-, LIG4-/- and LIG1-/-LIG4-/- 
cells after exposure to increasing doses of X-rays. B). As in A for LIG3-/2loxP, and 
LIG3-/-Cdc9 cells after treatment for 1h before and 4h after IR with 10 µM NU7441. The 
dashed lines trace for comparison the results of wt and Lig1-/-LIG4-/- cells. C) As in B for 
LIG3-/2loxP, LIG3-/M2I, LIG3-/2loxPLIG4-/-, and LIG3-/M2ILIG4-/- cells. D). As in B for clone 3 of 
LIG3-/2loxPLIG4-/-mts-hLig1 and LIG3-/-LIG4-/-mts-hLig1. Results from at least two 





Wt DT40 cells are modestly sensitive to IR, and exposure to 10 Gy kills about 
99% of the population (Figure 37A). Deletion of LIG1 has no consequences for 
the radiosensitivity of the corresponding knockout mutant suggesting that LIG1 
is not essential for the repair processes determining cell radiosensitivity to killing 
(Figure 37A). As expected, deletion of LIG4 causes a dramatic 
radiosensitization (Figure 37A). But this radiosensitization is not further impaired 
by deletion of LIG1 in the double mutant Lig1-/-LIG4-/-. In this mutant all ligation 
functions for the DNA metabolism including repair of all forms of radiation-
induced DNA lesions are carried out by LIG3, the only remaining DNA ligase 
(Paul et al., 2013). 
LIG3-/2loxP- cells display a radiosensitivity very similar to the wt and treatment 
with NU7441 radiosensitizes them to LIG4-/- levels (the radioresistant tail 
probably reflects ~5% of the cell population, which for unknown reasons is not 
responding to the drug) (Figure 37B). Notably, LIG3-/-Cdc9 cells are more 
radiosensitive than the wt (Figure 37B) pointing to a function of LIG3 in cell 
survival after exposure to IR even in the presence of LIG4, or to dominant 
negative effects exerted by the expression of Cdc9. However, after treatment 
with NU7441, LIG3-/-Cdc9 cells become indistinguishable from the single LIG4-/- 
mutant (Figure 37B). These results clearly suggest that LIG1 can substitute for 
LIG3 in repair functions related to cell survival with similar efficiency (Paul et al., 
2013). 
Also LIG3-/M2I cells display radiosensitivity very similar to wt cells, indicating that 
nuclear LIG3 is not essential for cell survival after exposure to IR (Figure 37C). 
Treatment with NU7441 radiosensitizes this mutant to the same extent as the 
LIG3-/2loxP or LIG3-/-Cdc9 cells, suggesting that the reduced level of nuclear 
LIG3 has in the presence of LIG1 no influence on cell radiosensitivity to killing, 
even when D-NHEJ is compromised (Paul et al., 2013). 
The double mutants LIG3-/2loxPLIG4-/- and LIG3-/M2ILIG4-/- show radiosensitivity 
indistinguishable from that of LIG4-/- cells (Figure 37C), indicating that a strong 
reduction in LIG3 levels leaves the ability of DT40 to deal with lethal radiation 




To further delineate the function of LIG1 on cell survival after exposure to IR, we 
examined clones ectopically expressing mts-hLIG1 either in the LIG3-/2loxPLIG4-/- 
or the LIG3-/-LIG4-/- genetic background (Figure 37D). Compared to 
LIG3-/2loxPLIG4-/- cells, LIG3-/-LIG4-/-mts-hLIG1 cells are slightly more 
radioresistant suggesting that overexpression of LIG1 provides a modest 
survival advantage to this mutant (Paul et al., 2013). 
We conclude from the obtained results that both LIG3 and LIG1 efficiently 






While LIG4 is solidly implicated in the D-NHEJ pathway of DSB repair, LIG1 is 
thought to play a central role in DNA replication by catalyzing Okazaki-fragment 
ligation at the replication fork on the lagging strand and in ligating the gaps 
generated during DSB repair by HR. On the other hand, LIG3 in vertebrates has 
been previously associated with the repair of single strand breaks and base 
damage, but now more and more publications implicate LIG3 as a major 
component of DSB repair by B-NHEJ (Audebert et al., 2004; Cotner-Gohara et 
al., 2010; Liang et al., 2008; Rosidi et al., 2008; Wang et al., 2005; Wang et al., 
2006).  
Although LIG1 was also implicated in the above repair pathway under certain 
conditions, it is still controversial whether LIG1 could substitute for the functions 
of LIG3 in the B-NHEJ repair pathway (Liang et al., 2008). However, the ligase 
responsible for B-NHEJ is less conclusively characterized, particularly because 
often the evidence was of biochemical nature and therefore of unknown 
physiological significance. For a conclusive elucidation of the function of LIG3 in 
B-NHEJ, here we focus on the contributions of LIG1 and LIG3 to DSB repair by 
studying the inherent functional flexibility of the ligase system, through the 
generation of a large set of knockout and knock-in mutants in the chicken DT40 
cell system (summarized in Table 5) (Paul et al., 2013). 
Our results confirm, in line with other studies from mouse systems (Gao et al., 
2011; Simsek et al., 2011b), that LIG3 knockout lethality can be rescued by 
expression of a ligase endowed with a mitochondria specific targeting signal. 
We could show that the mitochondria specific function of DT40 LIG3 can be 
supported by Cdc9, the yeast homolog of LIG1, and by human LIG1 with a 
mitochondrial targeting signal (mts-hLIG1). This has also very recently been 
demonstrated in mouse cells, where it could be shown that any member of the 
ligase family is able to support mitochondria function, if it carries an 
mitochondria specific targeting signal (Simsek et al., 2011b). Thus, it was 




other ligases than LIG3, while mitochondria functionality was maintained by 
different ligases (Paul et al., 2013). 
Noteworthy is that in other cell systems cell survival for several generations is 
possible after LIG3 knockout (Gao et al., 2011). This raises the question as to 
why DT40 cells die immediately after a significant reduction in LIG3 levels. As 
DT40 cells are chicken B cell lymphocytes they are more prone to apoptosis. In 
addition, due to their high proliferation rate of 10 h doubling time, their 
mitochondria content may be higher than usual. Since mitochondria store a set 
of apoptotic cell-suicide proteins (Wang and Youle, 2009), the induced 
mitochondrial malfunction by LIG3 depletion may cause the release of these 
proteins and the inception of apoptosis (Paul et al., 2013). 
Remarkably, peripheral blood monocytes (PBMCs) lack the DNA repair proteins 
XRCC1, LIG3α, PARP1 and DNA-PKcs but have intact mitochondria. PBMCs 
are non-dividing cells and consequently hypersensitive to DNA damage. 
Monocyte differentiation generates macrophages and dendritic cells, and 
interestingly these cells have restored XRCC1 and LIG3α protein levels and are 
resistant to methylating agents (Bauer et al., 2012). 
Notably, it is possible to generate cells that lack mitochondria by long-term 
treatment with low levels of ethidium bromide (Leibowitz, 1971). These cells are 
then resistant to apoptosis and cell death (Ferraresi et al., 2008; Park et al., 
2004). This observation indicates that DT40 specific parameters generate the 
response observed upon LIG3 depletion and requires further studies. 
In the present work and for the first time we were able to demonstrate in a clean 
genetic background an impressive and not previously appreciated potential of 
LIG3 to substitute for other ligases in all essential aspects of the DNA 
metabolism. The obtained PFGE results show that, while repair of DSBs is 
severely compromised in the absence of LIG4, efficient DSB rejoining is still 
possible, albeit with slower kinetics. Since this rejoining remains unchanged in 
the double LIG1-/-LIG4-/- mutant, where LIG3 is the sole remaining ligase, the 
contribution of LIG3 in DSB repair is unequivocally shown. Similar conclusions 
could be drawn from -H2AX foci kinetic data and survival curve data to 




Since alternative pathways of NHEJ operating as backup have been associated 
with various functions of the immune system and in telomere maintenance, the 
results also implicate LIG3 in genomic stability (McVey and Lee, 2008; 
Nussenzweig and Nussenzweig, 2007). LIG3 via B-NHEJ is predominantly 
responsible for the formation of chromosome translocations (Simsek et al., 
2011a), although this outcome is not a universal finding for LIG3 (Boboila et al., 
2012). Also the observation that in several cancer cell lines LIG3 is 
overexpressed, e.g. CML cell lines that are positive for BCR-ABL translocation 
(Chen et al., 2008), indicates an increased usage of LIG3 and B-NHEJ for DSB 
repair in this context (Sallmyr et al., 2008; Tobin et al., 2012a; Tobin et al., 
2012b). Possible functions of LIG3 in DSB repair are also supported by the 
impressive substrate flexibility of LIG3 (Tomkinson and Mackey, 1998) and its 
special domain structure. The N-terminal zinc finger domain of LIG3 normally 
serves as a nick sensor and mediates together with the catalytic core an 
intermolecular ligation (Cotner-Gohara et al., 2010). 
It is commonly thought that XRCC1 is a protein partner of LIG3 (Caldecott et al., 
1994) and that both molecules operate in a complex as they form a heterodimer 
through their BRCT domains (Caldecott, 2003). However, cells deficient in 
XRCC1 fail to show decreased usage of B-NHEJ as indicated by increased 
usage of microhomology (Verkaik et al., 2002). Interestingly, several recent 
reports uncoupled the function of LIG3 from XRCC1 in certain cellular functions 
(Gao et al., 2011; Simsek et al., 2011b) including repair of DSBs induced during 
Ig heavy chain class switch recombination by alternative end-joining; they 
conclude that XRCC1 is not a prerequisite factor for B-NHEJ (Boboila et al., 
2012). 
Therefore, we consider possible that in DT40 cells LIG3 operates in B-NHEJ 
without need for XRCC1. Additionally, in mammalian mitochondria XRCC1 is 
absent, indicating that LIG3 within the mitochondria does not require XRCC1 for 
function. In line with this, an interaction of LIG3α with mitochondrial polymerase 
 has been shown (De and Campbell, 2007). Since we were not able to identify 
a XRCC1 homolog in the known DT40 chicken genome, we are not in a position 
to conclusively address the question as to whether in DT40 cells LIG3 requires 




Our investigations revealed that LIG3, as sole cellular DNA ligase, supports 
repair of DSBs in a LIG1-/-LIG4-/- background. In these mutants deletion of LIG4 
compromises D-NHEJ, allowing DSB processing by LIG3 via B-NHEJ 
(Mladenov and Iliakis, 2011). Similarly, robust DSB repair via B-NHEJ is 
observed in LIG3-/-LIG4-/- mutants rescued with mts-hLIG1. In this mutant LIG1 
is the only remaining DNA ligase and covers for all ligation requirements of DSB 
repair, while the LIG4 knockout shifts DSB processing from D-NHEJ to B-NHEJ. 
In line with this, LIG3-/-Cdc9 cells, treated with NU7441 to compromise D-NHEJ, 
also showed an involvement of LIG1 in DSB repair via B-NHEJ which confirms 
the above findings. Together with the survival curve data the results point to a 
remarkable ability of LIG1 and LIG3 to support DSB repair by B-NHEJ with 
similar efficiency and in an apparently interchangeable manner (Paul et al., 
2013). 
Our results extend and modify earlier biochemical observations for LIG3 
(Audebert et al., 2004; Cotner-Gohara et al., 2010; Liang et al., 2008; Rosidi et 
al., 2008; Wang et al., 2006), which favored the function of the protein in 
B-NHEJ, although LIG1 was also implicated under certain conditions (Liang et 
al., 2008). The similarity between the protein structures of LIG1 and LIG3 offers 
an explanation of the functional overlap between these two enzymes (Pascal et 
al., 2004). However, the shown interchangeability of LIG1 and LIG3 in B-NHEJ 
does not exclude a functional differentiation deriving from differences in their 
protein domain structure, as both ligases have different interaction partner 
proteins, which modulate their capability for certain ligation functions in the DNA 
metabolism. One can argue that in the case of X-rays a large variety of 
biochemically distinct DSBs is induced and raises the possibility that certain 
types of DSBs are more efficiently processed by a particular ligase than others 
(Paul et al., 2013). 
It has been proposed that different alternative pathways of DSB repair exist, as 
LIG1 and LIG3 are differently involved in the formation of chromosome 
translocations initiated by I-SceI induced DSBs (Simsek et al., 2011a). Indeed, 
our results also suggest slight differences in the contribution of LIG1 and LIG3 
in B-NHEJ. Since LIG3-/M2ILIG4-/- cells, or LIG3-/-Cdc9 cells after treatment with 




to LIG4-/- or LIG1-/-LIG4-/- cells, perhaps a small subset of IR-induced DSBs is 
more efficiently processed by LIG3 than by LIG1. We assume only one existing 
B-NHEJ, which may use the proteins in a sequential manner, depending on 
their presence. This directly influences its outcome and whether microhomology 
is used, or not. It might be just convenient using it, but it is not a necessity 
(Mansour et al., 2010). We also like to point out that differences in the functions 
and use of LIG1 and LIG3 in B-HNEJ may be species specific, as in a mouse 
model system depletion of LIG1 generated a more severe effect than depletion 
of LIG3 (Gao et al., 2011) (Paul et al., 2013). 
However, from our results it is clear that the slight advantage of LIG3 in B-NHEJ 
can be compensated by overexpression of mts-hLIG1, which solidly integrates 
this ligase into B-NHEJ (Paul et al., 2013). Results from yeast, which generally 
lack LIG3, and from other eukaryotes, further support a function of LIG1 in 
B-NHEJ. In yeast, deletion of Dnl4, the homolog of LIG4, or its accessory factor 
Nej1 reduces DSB repair capability by an alternative pathway to 50% but does 
not completely compromise it. These results are consistent with a role of LIG1 
in alternative end-joining (Boulton and Jackson, 1996; Lee and Lee, 2007; Ma 
et al., 2003). In human cells, LIG1 has also been shown to be involved in 
alternative DSB repair (Liang et al., 2008), and also results obtained in B cells 
performing Ig class switch recombination indicate a role of LIG1 in alternative 
end-joining (Boboila et al., 2012). 
In the beginning it was thought that LIG3 is restricted to vertebrates, but recent 
phylogenetic tree studies based on comparisons on the DBD-CC for all three 
ligases, found LIG3 in 30% of the eukaryotes and 4 of the 6 ancestral 
eukaryotic groups, respectively. Usually the mitochondrial targeting signal 
(MTS) of LIG3 is used to predict the presence of this ligase in mitochondria. But 
in some organisms a PCNA-interacting peptide (PIP) box at the N-terminus of 
LIG1, where no obvious MTS is present in LIG3, makes it difficult to predict 
which ligase may be localized in the mitochondria of the investigated organism 





Since in lower eukaryotes replication and maintenance of mitochondria DNA is 
part of LIG1 functions, it will be interesting to consider the evolutionary 
advantages that are associated with the transfer of this function to LIG3 in 
vertebrates. Genome sequencing revealed that LIG3 arose much earlier in 
eukaryotic evolution than previously suspected. It follows that the absence of 
LIG3 from many eukaryotes suggests that LIG3 was also lost at several 
instances during evolution. As a result, closely related organisms can differ in 
the presence of LIG3 (Simsek and Jasin, 2011). 
The results in aggregate suggest that LIG1 and LIG3 operate flexibly in 
B-NHEJ. This enhances further the flexibility of B-NHEJ in the usage of 
participating factors (Paul et al., 2013). The apparent adaptability in participating 
factor selection of B-NHEJ is in stark contrast to the rigid repertoire of factors 
participating in D-NHEJ and may reflect its primordial nature (DiBiase et al., 
2000). 
Despite the potential deleterious consequences of B-NHEJ function, little is 
known about the underlying mechanism of B-NHEJ, its regulation, integration 
into the cellular DNA DSB processing apparatus and its interaction with 
components of D-NHEJ and HRR. Therefore, it could be possible that in certain 
cases, even in repair proficient cells, D-NHEJ fails in some way and thereby 
permits B-NHEJ to substitute for it. Likewise, it has been found that DNA 
end-resection, which generates single stranded DNA regions might facilitate the 
use of microhomology during B-NHEJ and leaves possible interdependencies 
between B-NHEJ and HRR open (Mladenov and Iliakis, 2011). Since DNA 
end-processing and the use of homology is an important component of HRR, it 
would be of great interest to investigate the extent to which irregular HRR 





In summary, the results outlined above provide the first solid genetic proof for 
an independent and robust function of both, LIG1 and LIG3 to DSB repair via 
B-NHEJ. They demonstrate an impressive and previously unrecognized 
potential interplay of LIG1 and LIG3 to participate interchangeably in DNA 
metabolisms (Paul et al., 2013). Recently published results in other cell systems 
(Boboila et al., 2012; Gao et al., 2011; Simsek et al., 2011b) confirm the 
restricted function of LIG4 in D-NHEJ. Together with our recent results on the 
ligation requirements of LIG3 in semi-conservative DNA replication (Arakawa et 
al., 2012), these findings suggest a functional redundancy between LIG1 and 
LIG3 in DNA replication, NER, and HRR, and a hierarchical relationships 
between LIG4, LIG3 and LIG1 in DSB repair that should contribute to the 
stability of vertebrate genomes. It is intriguing that such relationships developed 
only after the evolutionary appearance of LIG3, as LIG1 and LIG4 family 






Among the variety of lesions that are induced by ionizing radiation, the most 
critical one is the DNA double strand break (DSB). DSBs are highly cytotoxic 
lesions and if left unrepaired or are misrepaired can lead to chromosomal 
aberrations and induction of apoptosis or can result in mutations, genomic 
instability and carcinogenesis. Cells of higher eukaryotes use two major repair 
pathways to repair their DSBs: homologous recombination repair (HRR) and 
non-homologous end-joining (NHEJ). Previous biochemical and genetic studies 
from our lab support the view that vertebrates remove DSBs from their 
genomes predominantly by two non-homologous end joining (NHEJ) pathways, 
termed D-NHEJ and B-NHEJ. While D-NHEJ depends on the well characterized 
activities of DNA-dependent protein kinase (DNA-PK) and LIG4/XRCC4/XLF 
complexes, the activities and the mechanisms of the alternative, backup NHEJ 
are less well characterized. Previous studies from our laboratory implicated 
LIG3 together with PARP in B-NHEJ and histone H1 as an alignment factor. 
Notably, the contribution of LIG1 to B-NHEJ remains conjectural and although 
biochemical, cytogenetic and genetic experiments implicate LIG3, this 
contribution has not been formally demonstrated. 
DNA ligase III (LIG3) is beside DNA ligases I (LIG1) and IV (LIG4) one of three 
mammalian DNA ligases, unique in that it is restricted to vertebrates. The LIG3 
gene of higher eukaryotes generates four distinct DNA ligase polypeptides that 
serve nuclear and mitochondrial functions. The mitochondrial and nuclear 
versions LIG3α are synthesized from LIG3 mRNA by an alternative translation 
initiation mechanism. This N-terminal mitochondrial leader sequence is a unique 





To conclusively examine the function of LIG3 in B-NHEJ we generated a series 
of knockouts in the DT40 system system in cooperation with Hiroshi Arakawa 
from Helmholtz Center Munich. While LIG1-/- and LIG4-/- mutants are viable and 
grow normally, LIG3 knockout is lethal. Therefore, conditional knockout models 
were developed and combined with knockouts of all other DNA ligases to study 
the functions of LIG1 and LIG3 in DSB repair. 
To study the role of LIG1 in DSB repair we knocked out this ligase in wt and 
LIG4-/- genetic background to generate cells deficient in LIG1-/- and double 
mutants deficient in LIG1-/-LIG4-/-. There is no effect on the repair of DSBs 
measured by PFGE in LIG1-/- cells suggesting that this ligase has no 
measurable contribution to the repair of this form of DNA lesion. LIG4-/- cells 
show a pronounced defect in DSB repair due to the inhibition of D-NHEJ. 
However, these cells are capable of repairing the majority of IR induced DSBs 
using B-NHEJ. The repair of the generated double LIG1-/-LIG4-/- knockout 
mutant was indistinguishable from that of LIG4-/- cells providing thus conclusive 
evidence that a. LIG1 is not required for the repair of DSBs either by B-NHEJ or 
D-NHEJ, if LIG3 is present and functional and b. that LIG3, the only remaining 
DNA ligase in this mutant, is an integral component of B-NHEJ. The results 
were confirmed at low doses in -H2AX foci kinetics and in cell survival assays. 
In addition, our results confirm, that LIG3 is essential for survival of higher 
eukaryotic cells due to its function in the mitochondria. In line with other studies, 
the LIG3 knockout lethality can be rescued by expression of a ligase endowed 
with a mitochondria specific targeting sequence. To conclusively determine the 
role of LIG1 in DSB repair, we took advantage of these findings and developed 
a genetic system devoid of LIG3. Therefore we generated cells expressing 
hLIG1 with a mitochondrial targeting sequence (mts-hLIG1) in the LIG3-/-LIG4-/- 
genetic background. DSB repair studies of the generated 
LIG3-/-LIG4-/-mts-hLIG1 mutants show a DSB processing with no difference in 
comparison to double LIG1-/-LIG4-/- knockout mutants. Since these mutants 
express only the endogenous chicken LIG1 and the overexpressed 
mitochondrial human LIG1, we can conclude that also LIG1 is able to support 




In summary, the results obtained expand the functions of LIG1 to alternative 
NHEJ and demonstrate a remarkable ability for LIG3 to backup DSB repair by 
B-NHEJ, in addition to its essential function in the mitochondria. Together with 
our recent results on DNA replication, these observations uncover a remarkable 
and previously unappreciated functional flexibility and interchangeability 
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